| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP34 USP17L21 USP17L23 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 MINDY4 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP8 USP17L6P USP17L22 USP17L15 USP17L8 | 4.15e-21 | 114 | 296 | 24 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP34 USP17L21 USP17L23 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 MINDY4 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP8 USP17L6P USP17L22 USP17L15 USP17L8 | 3.43e-20 | 124 | 296 | 24 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP34 USP17L21 USP17L23 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 MINDY4 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP8 USP17L6P USP17L22 USP17L15 USP17L8 | 4.02e-19 | 137 | 296 | 24 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP34 USP17L21 USP17L23 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 MINDY4 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 CAPN2 USP17L24 USP24 USP17L5 USP17L10 USP8 USP17L6P USP17L22 USP17L15 USP17L8 | 1.13e-16 | 192 | 296 | 25 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | USP34 USP17L21 USP17L23 USP17L1 USP17L20 ERVK-7 USP17L19 ERVK-10 USP17L18 USP17L17 MINDY4 ERVK-24 USP17L13 USP17L4 USP17L2 NUDT16 USP17L12 USP28 USP17L11 CAPN2 USP17L24 USP24 USP17L5 USP17L10 USP8 USP17L6P USP17L22 USP17L15 USP17L8 | 1.63e-07 | 654 | 296 | 29 | GO:0008233 |
| GeneOntologyMolecularFunction | calcium ion binding | CIB3 RYR1 PCDH17 TBC1D9 RYR3 ITPR1 ITPR2 ITPR3 EHD2 FAM20C FAT1 MAN1A2 DST OTOF PCDHB1 FAT4 CRACR2A PCDHGA2 FAT3 CAPN2 CRTAC1 LCP1 RAB44 TKT LRP4 MACF1 UNC13C RAPGEF2 UNC13A | 2.55e-06 | 749 | 296 | 29 | GO:0005509 |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 3.22e-06 | 3 | 296 | 3 | GO:0005220 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | ATR OBSCN IRAK1 CDK11A MAP3K5 CDC7 TAOK2 STK32A STK4 PHKA2 FAM20C MYO3A CIITA DSTYK LATS2 CSNK1G2 IRAK3 EIF2AK4 PRKG1 MAPK6 FAM20A | 3.52e-06 | 446 | 296 | 21 | GO:0004674 |
| GeneOntologyMolecularFunction | protein kinase activity | ATR OBSCN IRAK1 CDK11A MAP3K5 CDC7 TAOK2 STK32A STK4 PHKA2 FAM20C MYO3A CIITA DSTYK FES NTRK2 LCK RNASEL LATS2 CSNK1G2 IRAK3 EIF2AK4 PRKG1 MAPK6 FAM20A | 3.66e-06 | 600 | 296 | 25 | GO:0004672 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 5.06e-06 | 18 | 296 | 5 | GO:0015278 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | ATR OBSCN IRAK1 CDK11A MAP3K5 CDC7 TAOK2 STK32A STK4 PHKA2 FAM20C MYO3A CIITA DSTYK FES KHK NTRK2 LCK RNASEL LATS2 CSNK1G2 IRAK3 EIF2AK4 PRKG1 COASY MAPK6 FAM20A | 7.78e-06 | 709 | 296 | 27 | GO:0016773 |
| GeneOntologyMolecularFunction | protein serine kinase activity | ATR OBSCN IRAK1 CDK11A MAP3K5 CDC7 TAOK2 STK32A STK4 FAM20C MYO3A CIITA DSTYK LATS2 CSNK1G2 EIF2AK4 PRKG1 MAPK6 | 8.81e-06 | 363 | 296 | 18 | GO:0106310 |
| GeneOntologyMolecularFunction | calmodulin binding | MYH10 MYH13 MYO7A OBSCN RYR1 RYR3 PHKA2 MYO3A EEA1 STRN3 UNC13C ATP2B1 UNC13A INVS | 9.24e-06 | 230 | 296 | 14 | GO:0005516 |
| GeneOntologyMolecularFunction | kinase activity | ATR OBSCN IRAK1 CDK11A PGK1 MAP3K5 CDC7 TAOK2 STK32A STK4 PHKA2 FAM20C MYO3A CIITA DSTYK FES KHK NTRK2 LCK RNASEL LATS2 CSNK1G2 IRAK3 EIF2AK4 PRKG1 COASY MAPK6 FAM20A | 1.07e-05 | 764 | 296 | 28 | GO:0016301 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ATR OBSCN IRAK1 CDK11A ERVK-7 ERVK-10 PGK1 MAP3K5 CDC7 TAOK2 STK32A STK4 PHKA2 FAM20C MYO3A CIITA DSTYK FES KHK NTRK2 LCK TRNT1 RNASEL LATS2 CSNK1G2 IRAK3 EIF2AK4 PRKG1 COASY MAPK6 FAM20A | 2.69e-05 | 938 | 296 | 31 | GO:0016772 |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 8.57e-05 | 31 | 296 | 5 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.17e-04 | 33 | 296 | 5 | GO:0005217 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.32e-04 | 21 | 296 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | magnesium ion binding | CIB3 PGM1 PGM5 MAP3K5 STK4 MOV10L1 GLUL NUDT16 IDH2 ATP10D TKT IRAK3 | 3.36e-04 | 247 | 296 | 12 | GO:0000287 |
| GeneOntologyMolecularFunction | phosphoglucomutase activity | 6.51e-04 | 3 | 296 | 2 | GO:0004614 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH10 MYH13 MYO7A MYO3A MOV10L1 SHOC1 HELZ CHD6 ATP13A3 KIF17 HSPA1L HSPA6 HSPA7 KIF21A RNF213 ATP10D KIF3A ACIN1 MACF1 ATP2B1 | 8.91e-04 | 614 | 296 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 1.04e-03 | 14 | 296 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.29e-03 | 4 | 296 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | spectrin binding | 1.55e-03 | 34 | 296 | 4 | GO:0030507 | |
| GeneOntologyMolecularFunction | diacylglycerol binding | 1.56e-03 | 16 | 296 | 3 | GO:0019992 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RAPGEF6 MCF2L2 OBSCN CHN1 CHN2 TBC1D9 SBF1 TBC1D1 DOCK1 GPS1 RAPGEF4 ARFGEF2 ARAP3 KNDC1 AKAP13 RAPGEF2 MTSS2 | 1.58e-03 | 507 | 296 | 17 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RAPGEF6 MCF2L2 OBSCN CHN1 CHN2 TBC1D9 SBF1 TBC1D1 DOCK1 GPS1 RAPGEF4 ARFGEF2 ARAP3 KNDC1 AKAP13 RAPGEF2 MTSS2 | 1.58e-03 | 507 | 296 | 17 | GO:0030695 |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 1.72e-03 | 35 | 296 | 4 | GO:0043325 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.90e-03 | 118 | 296 | 7 | GO:0003774 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 MINDY4 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP8 USP17L6P USP17L22 USP17L15 USP17L8 | 3.01e-19 | 125 | 294 | 23 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 MINDY4 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 GPS1 USP17L24 USP24 USP17L5 USP17L10 USP8 USP17L6P USP17L22 USP17L15 USP17L8 | 5.58e-19 | 144 | 294 | 24 | GO:0070646 |
| GeneOntologyBiologicalProcess | protein autophosphorylation | NLRP12 ATR OBSCN IRAK1 TAOK2 STK4 FAM20C MYO3A FES NTRK2 LCK IRAK3 EIF2AK4 | 2.56e-05 | 228 | 294 | 13 | GO:0046777 |
| GeneOntologyCellularComponent | Golgi cis cisterna | 6.52e-06 | 33 | 299 | 6 | GO:0000137 | |
| GeneOntologyCellularComponent | cell cortex | MYH10 MYO7A RYR1 ITPR2 DST EXOC6 CAPN2 PPFIA3 SPTBN4 CSNK1G2 MACF1 AKAP13 CTBP2 UNC13C UNC13A MTSS2 | 9.63e-05 | 371 | 299 | 16 | GO:0005938 |
| GeneOntologyCellularComponent | postsynapse | MYH10 ATR GAPDH ZMYND8 RPS23 ITGB3 PCDH17 ITPR1 TAOK2 DST PTPRZ1 SORCS2 EEA1 KIF17 DOCK1 STRN3 NTRK2 EGLN1 CAPN2 RAPGEF4 ARFGEF2 CRTAC1 LCK KIF3A USP8 LRP4 MACF1 IGSF9B RAPGEF2 ATP2B1 | 1.51e-04 | 1018 | 299 | 30 | GO:0098794 |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 2.28e-04 | 9 | 299 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 2.93e-04 | 23 | 299 | 4 | GO:0098831 | |
| GeneOntologyCellularComponent | glutamatergic synapse | MYH10 GAPDH ITGB3 PCDH17 TAOK2 SEMA3A PTPRZ1 EEA1 PLXNA1 DOCK1 PRUNE2 NTRK2 EGLN1 CNTNAP1 RAPGEF4 ARFGEF2 PORCN CRTAC1 LCK PPFIA3 KIF3A USP8 CTBP2 ATP2B1 UNC13A | 3.12e-04 | 817 | 299 | 25 | GO:0098978 |
| GeneOntologyCellularComponent | Z disc | 3.33e-04 | 151 | 299 | 9 | GO:0030018 | |
| GeneOntologyCellularComponent | somatodendritic compartment | MYH10 ZMYND8 GOLGA8N ITPR1 ITPR3 TAOK2 SEMA3A ERCC8 PTPN6 PTPRZ1 DHODH GLUL SORCS2 RAB2A KIF17 STRN3 NTRK2 FAT3 KIF21A CAPN2 RAPGEF4 ARFGEF2 GOLGA8K APOB KIF3A SPTBN4 USP8 KNDC1 LRP4 IGSF9B RAPGEF2 GOLGA8O ATP2B1 | 3.79e-04 | 1228 | 299 | 33 | GO:0036477 |
| GeneOntologyCellularComponent | cell body | MYH10 GOLGA8N ITPR1 ITPR3 ERCC8 PTPN13 PTPRZ1 DHODH GLUL SORCS2 RAB2A HSPA1L STRN3 NTRK2 CAPN2 RAPGEF4 GOLGA8K APOB KIF3A RLBP1 SPTBN4 KNDC1 LRP4 IGSF9B RAPGEF2 GOLGA8O ATP2B1 | 4.04e-04 | 929 | 299 | 27 | GO:0044297 |
| GeneOntologyCellularComponent | myosin filament | 4.09e-04 | 25 | 299 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 4.39e-04 | 11 | 299 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L21 USP17L1 USP17L20 USP17L19 RYR1 RYR3 MAP3K5 ITPR1 ITPR2 ITPR3 USP17L18 LPIN1 DST SBF1 USP17L17 OTOF RAB2A USP17L13 USP17L4 USP17L2 USP17L12 TAPBPL USP17L11 PORCN USP17L5 USP17L10 APOB ATP10D TKT OSBPL3 USP17L6P USP17L22 USP17L15 USP17L8 | 4.56e-04 | 1293 | 299 | 34 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L21 USP17L1 USP17L20 USP17L19 RYR1 RYR3 MAP3K5 ITPR1 ITPR2 ITPR3 USP17L18 LPIN1 DST SBF1 USP17L17 OTOF RAB2A USP17L13 USP17L4 USP17L2 USP17L12 TAPBPL USP17L11 PORCN USP17L5 USP17L10 APOB ATP10D TKT OSBPL3 USP17L6P USP17L22 USP17L15 USP17L8 | 4.95e-04 | 1299 | 299 | 34 | GO:0098827 |
| GeneOntologyCellularComponent | I band | 6.64e-04 | 166 | 299 | 9 | GO:0031674 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L21 USP17L1 USP17L20 USP17L19 RYR1 RYR3 MAP3K5 ITPR1 ITPR2 ITPR3 USP17L18 LPIN1 DST SBF1 USP17L17 OTOF RAB2A USP17L13 USP17L4 USP17L2 USP17L12 TAPBPL USP17L11 PORCN USP17L5 USP17L10 APOB ATP10D TKT OSBPL3 USP17L6P USP17L22 USP17L15 USP17L8 | 7.20e-04 | 1327 | 299 | 34 | GO:0042175 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | GTPBP4 GAPDH NMRAL1 RYR1 RYR3 GOLGA8N ITPR1 ITPR3 EHD2 FAT1 DST SBF1 RAB2A EXOC6 UACA NTRK2 CAPN2 ARFGEF2 FSD2 GOLGA8K LCP1 OSBPL3 RTRAF AKAP13 RAPGEF2 GOLGA8O | 9.70e-04 | 934 | 299 | 26 | GO:0048471 |
| GeneOntologyCellularComponent | presynaptic active zone | 9.78e-04 | 141 | 299 | 8 | GO:0048786 | |
| GeneOntologyCellularComponent | neuronal cell body | MYH10 GOLGA8N ITPR1 ITPR3 ERCC8 PTPRZ1 DHODH GLUL SORCS2 RAB2A STRN3 NTRK2 CAPN2 RAPGEF4 GOLGA8K APOB KIF3A SPTBN4 KNDC1 LRP4 IGSF9B RAPGEF2 GOLGA8O ATP2B1 | 9.85e-04 | 835 | 299 | 24 | GO:0043025 |
| GeneOntologyCellularComponent | ribbon synapse | 1.08e-03 | 32 | 299 | 4 | GO:0097470 | |
| GeneOntologyCellularComponent | integrin complex | 1.08e-03 | 32 | 299 | 4 | GO:0008305 | |
| GeneOntologyCellularComponent | sarcoplasm | 1.28e-03 | 114 | 299 | 7 | GO:0016528 | |
| GeneOntologyCellularComponent | cis-Golgi network | 1.38e-03 | 85 | 299 | 6 | GO:0005801 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH10 MYH13 PPP1R12A OBSCN EML2 NEB PGM1 RYR1 RYR3 PGM5 GOLGA8N MYO3A DST KRT71 KIF17 COL2A1 KRT3 COL6A3 KIF21A ARFGEF2 GOLGA8K LCP1 KIF3A SPTBN4 MACF1 AKAP13 MYOM2 GOLGA8O INVS AHNAK2 | 1.65e-03 | 1179 | 299 | 30 | GO:0099512 |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 1.65e-03 | 88 | 299 | 6 | GO:0016529 | |
| GeneOntologyCellularComponent | supramolecular polymer | MYH10 MYH13 PPP1R12A OBSCN EML2 NEB PGM1 RYR1 RYR3 PGM5 GOLGA8N MYO3A DST KRT71 KIF17 COL2A1 KRT3 COL6A3 KIF21A ARFGEF2 GOLGA8K LCP1 KIF3A SPTBN4 MACF1 AKAP13 MYOM2 GOLGA8O INVS AHNAK2 | 1.83e-03 | 1187 | 299 | 30 | GO:0099081 |
| GeneOntologyCellularComponent | myofibril | MYH13 PPP1R12A OBSCN NEB PGM1 RYR1 RYR3 PGM5 DST MYOM2 AHNAK2 | 2.01e-03 | 273 | 299 | 11 | GO:0030016 |
| GeneOntologyCellularComponent | COP9 signalosome | 2.06e-03 | 38 | 299 | 4 | GO:0008180 | |
| GeneOntologyCellularComponent | Golgi cisterna membrane | 2.31e-03 | 94 | 299 | 6 | GO:0032580 | |
| Domain | UCH | USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP8 USP17L22 USP17L8 | 2.69e-20 | 71 | 285 | 20 | PF00443 |
| Domain | USP_2 | USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP8 USP17L22 USP17L8 | 2.69e-20 | 71 | 285 | 20 | PS00973 |
| Domain | USP_dom | USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP8 USP17L22 USP17L8 | 3.68e-20 | 72 | 285 | 20 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP8 USP17L22 USP17L8 | 3.68e-20 | 72 | 285 | 20 | IPR001394 |
| Domain | USP_3 | USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP8 USP17L22 USP17L8 | 3.68e-20 | 72 | 285 | 20 | PS50235 |
| Domain | USP_CS | USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP8 USP17L22 USP17L8 | 1.53e-19 | 66 | 285 | 19 | IPR018200 |
| Domain | HABP4_PAI-RBP1 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 2.18e-19 | 16 | 285 | 12 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 2.18e-19 | 16 | 285 | 12 | IPR006861 |
| Domain | USP_1 | USP34 USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP8 USP17L22 USP17L8 | 5.31e-19 | 70 | 285 | 19 | PS00972 |
| Domain | Ryanodine_recept-rel | 4.73e-09 | 6 | 285 | 5 | IPR015925 | |
| Domain | - | 4.73e-09 | 6 | 285 | 5 | 1.25.10.30 | |
| Domain | RIH_assoc-dom | 4.73e-09 | 6 | 285 | 5 | IPR013662 | |
| Domain | Ins145_P3_rec | 4.73e-09 | 6 | 285 | 5 | PF08709 | |
| Domain | RIH_assoc | 4.73e-09 | 6 | 285 | 5 | PF08454 | |
| Domain | RIH_dom | 4.73e-09 | 6 | 285 | 5 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 4.73e-09 | 6 | 285 | 5 | IPR014821 | |
| Domain | RYDR_ITPR | 4.73e-09 | 6 | 285 | 5 | PF01365 | |
| Domain | MIR | 1.89e-07 | 10 | 285 | 5 | PF02815 | |
| Domain | MIR_motif | 1.89e-07 | 10 | 285 | 5 | IPR016093 | |
| Domain | MIR | 1.89e-07 | 10 | 285 | 5 | PS50919 | |
| Domain | MIR | 1.89e-07 | 10 | 285 | 5 | SM00472 | |
| Domain | Kinase-like_dom | ATR OBSCN IRAK1 CDK11A MAP3K5 CDC7 TAOK2 STK32A STK4 MYO3A PTPN13 DST DSTYK FES NTRK2 LCK RNASEL LATS2 CSNK1G2 KNDC1 MACF1 IRAK3 EIF2AK4 PRKG1 MAPK6 | 9.74e-07 | 542 | 285 | 25 | IPR011009 |
| Domain | InsP3_rcpt-bd | 3.52e-06 | 3 | 285 | 3 | IPR000493 | |
| Domain | FG_GAP | 1.70e-05 | 22 | 285 | 5 | PS51470 | |
| Domain | FG-GAP | 2.68e-05 | 24 | 285 | 5 | PF01839 | |
| Domain | FG-GAP | 2.68e-05 | 24 | 285 | 5 | IPR013517 | |
| Domain | PROTEIN_KINASE_ATP | OBSCN IRAK1 CDK11A MAP3K5 CDC7 TAOK2 STK32A STK4 MYO3A DSTYK FES NTRK2 LCK RNASEL LATS2 CSNK1G2 IRAK3 EIF2AK4 PRKG1 MAPK6 | 2.77e-05 | 459 | 285 | 20 | PS00107 |
| Domain | Prot_kinase_dom | OBSCN IRAK1 CDK11A MAP3K5 CDC7 TAOK2 STK32A STK4 MYO3A DSTYK FES NTRK2 LCK RNASEL LATS2 CSNK1G2 IRAK3 EIF2AK4 PRKG1 MAPK6 | 6.70e-05 | 489 | 285 | 20 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | OBSCN IRAK1 CDK11A MAP3K5 CDC7 TAOK2 STK32A STK4 MYO3A DSTYK FES NTRK2 LCK RNASEL LATS2 CSNK1G2 IRAK3 EIF2AK4 PRKG1 MAPK6 | 7.48e-05 | 493 | 285 | 20 | PS50011 |
| Domain | Protein_kinase_ATP_BS | OBSCN IRAK1 MAP3K5 CDC7 TAOK2 STK32A STK4 MYO3A DSTYK FES NTRK2 LCK LATS2 CSNK1G2 EIF2AK4 PRKG1 MAPK6 | 7.81e-05 | 379 | 285 | 17 | IPR017441 |
| Domain | Pkinase | OBSCN IRAK1 CDK11A MAP3K5 CDC7 TAOK2 STK32A STK4 MYO3A DSTYK RNASEL LATS2 CSNK1G2 IRAK3 EIF2AK4 PRKG1 MAPK6 | 8.33e-05 | 381 | 285 | 17 | PF00069 |
| Domain | IQ | 1.03e-04 | 71 | 285 | 7 | PF00612 | |
| Domain | Ser/Thr_kinase_AS | OBSCN IRAK1 CDK11A MAP3K5 CDC7 TAOK2 STK32A STK4 MYO3A DSTYK LATS2 CSNK1G2 IRAK3 EIF2AK4 PRKG1 MAPK6 | 1.28e-04 | 357 | 285 | 16 | IPR008271 |
| Domain | S_TKc | OBSCN IRAK1 CDK11A MAP3K5 CDC7 TAOK2 STK32A STK4 MYO3A DSTYK RNASEL LATS2 CSNK1G2 EIF2AK4 PRKG1 MAPK6 | 1.36e-04 | 359 | 285 | 16 | SM00220 |
| Domain | PROTEIN_KINASE_ST | OBSCN IRAK1 CDK11A MAP3K5 CDC7 TAOK2 STK32A STK4 MYO3A DSTYK LATS2 CSNK1G2 IRAK3 EIF2AK4 PRKG1 MAPK6 | 1.50e-04 | 362 | 285 | 16 | PS00108 |
| Domain | Int_alpha | 1.72e-04 | 19 | 285 | 4 | SM00191 | |
| Domain | Int_alpha_beta-p | 1.72e-04 | 19 | 285 | 4 | IPR013519 | |
| Domain | RA | 2.04e-04 | 36 | 285 | 5 | PF00788 | |
| Domain | RasGEFN | 2.12e-04 | 20 | 285 | 4 | SM00229 | |
| Domain | Nop52 | 2.32e-04 | 2 | 285 | 2 | IPR010301 | |
| Domain | CHN1/CHN2 | 2.32e-04 | 2 | 285 | 2 | IPR017356 | |
| Domain | Nop52 | 2.32e-04 | 2 | 285 | 2 | PF05997 | |
| Domain | FAM21 | 2.32e-04 | 2 | 285 | 2 | IPR027308 | |
| Domain | IQ | 2.37e-04 | 81 | 285 | 7 | SM00015 | |
| Domain | RasGEF_N | 2.59e-04 | 21 | 285 | 4 | PF00618 | |
| Domain | LAM_G_DOMAIN | 2.65e-04 | 38 | 285 | 5 | PS50025 | |
| Domain | Ras-like_Gua-exchang_fac_N | 3.13e-04 | 22 | 285 | 4 | IPR000651 | |
| Domain | RASGEF_NTER | 3.13e-04 | 22 | 285 | 4 | PS50212 | |
| Domain | RA_dom | 3.39e-04 | 40 | 285 | 5 | IPR000159 | |
| Domain | Laminin_G_2 | 3.39e-04 | 40 | 285 | 5 | PF02210 | |
| Domain | ACTININ_2 | 3.74e-04 | 23 | 285 | 4 | PS00020 | |
| Domain | ACTININ_1 | 3.74e-04 | 23 | 285 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 3.74e-04 | 23 | 285 | 4 | IPR001589 | |
| Domain | tRNA-bd_arm | 4.43e-04 | 24 | 285 | 4 | IPR010978 | |
| Domain | IQ_motif_EF-hand-BS | 4.54e-04 | 90 | 285 | 7 | IPR000048 | |
| Domain | Integrin_dom | 5.22e-04 | 25 | 285 | 4 | IPR032695 | |
| Domain | LamG | 5.33e-04 | 44 | 285 | 5 | SM00282 | |
| Domain | IQ | 5.54e-04 | 93 | 285 | 7 | PS50096 | |
| Domain | Fam20C | 6.89e-04 | 3 | 285 | 2 | PF06702 | |
| Domain | CAP-ZIP_m | 6.89e-04 | 3 | 285 | 2 | PF15255 | |
| Domain | FAM20 | 6.89e-04 | 3 | 285 | 2 | IPR024869 | |
| Domain | Unc-13 | 6.89e-04 | 3 | 285 | 2 | IPR027080 | |
| Domain | FAM21/CAPZIP | 6.89e-04 | 3 | 285 | 2 | IPR029341 | |
| Domain | RyR | 6.89e-04 | 3 | 285 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 6.89e-04 | 3 | 285 | 2 | PF06459 | |
| Domain | Ryan_recept | 6.89e-04 | 3 | 285 | 2 | IPR013333 | |
| Domain | FAM20_C | 6.89e-04 | 3 | 285 | 2 | IPR009581 | |
| Domain | Ryanodine_rcpt | 6.89e-04 | 3 | 285 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 6.89e-04 | 3 | 285 | 2 | IPR009460 | |
| Domain | RASGEF_CAT | 9.33e-04 | 29 | 285 | 4 | PS50009 | |
| Domain | RasGEF | 1.06e-03 | 30 | 285 | 4 | PF00617 | |
| Domain | - | 1.06e-03 | 30 | 285 | 4 | 1.10.840.10 | |
| Domain | RASGEF_cat_dom | 1.06e-03 | 30 | 285 | 4 | IPR001895 | |
| Domain | RasGEF | 1.06e-03 | 30 | 285 | 4 | SM00147 | |
| Domain | Ras_GEF_dom | 1.06e-03 | 30 | 285 | 4 | IPR023578 | |
| Domain | SPEC | 1.36e-03 | 32 | 285 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.36e-03 | 32 | 285 | 4 | IPR018159 | |
| Domain | PGM_PMM_III | 1.36e-03 | 4 | 285 | 2 | PF02880 | |
| Domain | A-D-PHexomutase_CS | 1.36e-03 | 4 | 285 | 2 | IPR016066 | |
| Domain | A-D-PHexomutase_a/b/a-III | 1.36e-03 | 4 | 285 | 2 | IPR005846 | |
| Domain | Death | 1.53e-03 | 33 | 285 | 4 | PF00531 | |
| Domain | VWFA | 1.59e-03 | 82 | 285 | 6 | PS50234 | |
| Domain | HSP70 | 1.70e-03 | 16 | 285 | 3 | PF00012 | |
| Domain | cNMP | 1.72e-03 | 34 | 285 | 4 | SM00100 | |
| Domain | cNMP_binding | 1.72e-03 | 34 | 285 | 4 | PF00027 | |
| Domain | VWA | 1.80e-03 | 84 | 285 | 6 | SM00327 | |
| Domain | Laminin_G | 1.89e-03 | 58 | 285 | 5 | IPR001791 | |
| Domain | cNMP-bd_dom | 1.92e-03 | 35 | 285 | 4 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 1.92e-03 | 35 | 285 | 4 | PS50042 | |
| Domain | CA | 1.93e-03 | 115 | 285 | 7 | SM00112 | |
| Domain | HSP70_2 | 2.04e-03 | 17 | 285 | 3 | PS00329 | |
| Domain | HSP70_1 | 2.04e-03 | 17 | 285 | 3 | PS00297 | |
| Domain | HSP70_3 | 2.04e-03 | 17 | 285 | 3 | PS01036 | |
| Domain | Cadherin | 2.23e-03 | 118 | 285 | 7 | IPR002126 | |
| Domain | Munc13_dom-2 | 2.25e-03 | 5 | 285 | 2 | IPR014772 | |
| Domain | TF_AP2 | 2.25e-03 | 5 | 285 | 2 | IPR004979 | |
| Domain | Ferlin_B-domain | 2.25e-03 | 5 | 285 | 2 | IPR012561 | |
| Domain | TF_AP2_C | 2.25e-03 | 5 | 285 | 2 | IPR013854 | |
| Domain | Ferlin_C | 2.25e-03 | 5 | 285 | 2 | PF16165 | |
| Domain | PGM_PMM | 2.25e-03 | 5 | 285 | 2 | PS00710 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 9.82e-20 | 45 | 223 | 17 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP24 USP17L5 USP17L10 USP8 USP17L6P USP17L22 USP17L15 USP17L8 | 2.78e-12 | 191 | 223 | 21 | MM15289 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP8 USP17L22 USP17L15 USP17L8 | 4.60e-11 | 221 | 223 | 21 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP24 USP17L5 USP17L10 USP8 USP17L6P USP17L22 USP17L15 USP17L8 | 1.09e-09 | 262 | 223 | 21 | MM15286 |
| Pathway | REACTOME_DEUBIQUITINATION | USP34 USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP28 USP17L11 USP17L24 USP24 USP17L5 USP17L10 USP8 USP17L22 USP17L15 USP17L8 | 1.15e-08 | 299 | 223 | 21 | M27574 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L21 USP17L1 USP17L20 USP17L19 ITGB3 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 SPTBN4 USP17L6P RAPGEF2 MAPK6 USP17L22 USP17L15 USP17L8 | 3.37e-08 | 318 | 223 | 21 | MM15278 |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.35e-07 | 19 | 223 | 6 | M47760 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 3.82e-05 | 5 | 223 | 3 | M49000 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.90e-05 | 13 | 223 | 4 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 3.90e-05 | 13 | 223 | 4 | M47751 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 7.54e-05 | 6 | 223 | 3 | M47960 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.95e-04 | 76 | 223 | 7 | MM15051 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.96e-04 | 19 | 223 | 4 | M47733 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 2.01e-04 | 54 | 223 | 6 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 2.01e-04 | 54 | 223 | 6 | MM15202 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 2.42e-04 | 20 | 223 | 4 | M47688 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP34 USP17L21 USP17L1 USP17L20 RPS23 USP17L19 GOLGA8N USP17L18 ERCC8 FAM20C SERPINA1 MAN1A2 USP17L17 RAB2A USP17L13 GPLD1 USP17L4 USP17L2 USP17L12 USP28 USP17L11 GPS1 USP24 USP17L5 GOLGA8K USP17L10 APOB RENBP RAB44 SPTBN4 USP8 USP17L6P USP17L22 GOLGA8O FAM20A USP17L15 TP53BP1 USP17L8 WDTC1 | 2.76e-04 | 1389 | 223 | 39 | MM15307 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 2.95e-04 | 21 | 223 | 4 | M47689 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 3.06e-04 | 9 | 223 | 3 | M47852 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.56e-04 | 22 | 223 | 4 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.56e-04 | 22 | 223 | 4 | M47675 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 4.20e-04 | 86 | 223 | 7 | M916 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.26e-04 | 23 | 223 | 4 | M47676 | |
| Pathway | REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION | 4.26e-04 | 23 | 223 | 4 | MM14620 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 4.32e-04 | 10 | 223 | 3 | M47661 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP34 USP17L21 USP17L1 USP17L20 RPS23 USP17L19 USP17L18 ERCC8 FAM20C SERPINA1 MAN1A2 GANAB USP17L17 RAB2A USP17L13 GPLD1 USP17L4 USP17L2 USP17L12 USP28 USP17L11 GPS1 USP17L24 USP24 USP17L5 USP17L10 APOB RENBP ASB15 RAB44 TFAP2A SPTBN4 USP8 ARSL USP17L22 FAM20A USP17L15 TP53BP1 USP17L8 WDTC1 | 4.64e-04 | 1475 | 223 | 40 | M19806 |
| Pathway | WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER | 5.00e-04 | 42 | 223 | 5 | M39740 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 5.87e-04 | 11 | 223 | 3 | M49033 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 5.87e-04 | 11 | 223 | 3 | M27466 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 6.93e-04 | 26 | 223 | 4 | M47 | |
| Pathway | REACTOME_HEMOSTASIS | ISLR ITGAL ITGB3 ITPR1 ITPR2 ITPR3 EHD2 SERPINA1 PTPN6 GLG1 MFN2 DOCK1 KIF21A RAPGEF4 APOB LCK KIF3A AKAP10 PRKG1 ATP2B1 | 7.51e-04 | 571 | 223 | 20 | MM14472 |
| Pathway | REACTOME_PECAM1_INTERACTIONS | 7.73e-04 | 12 | 223 | 3 | MM14835 | |
| Pathway | REACTOME_PECAM1_INTERACTIONS | 7.73e-04 | 12 | 223 | 3 | M11773 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 8.04e-04 | 27 | 223 | 4 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 9.26e-04 | 28 | 223 | 4 | M924 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 9.93e-04 | 13 | 223 | 3 | M39589 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 9.93e-04 | 13 | 223 | 3 | M47656 | |
| Pathway | WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS | 9.93e-04 | 13 | 223 | 3 | M39463 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 9.93e-04 | 13 | 223 | 3 | MM14553 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.15e-32 | 21 | 301 | 17 | 8622927 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.15e-32 | 21 | 301 | 17 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.15e-32 | 21 | 301 | 17 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.15e-32 | 21 | 301 | 17 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.15e-32 | 21 | 301 | 17 | 12447969 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.15e-32 | 21 | 301 | 17 | 18980247 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 SP110 USP17L6P USP17L22 USP17L15 USP17L8 | 6.52e-32 | 26 | 301 | 18 | 35816173 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.38e-31 | 22 | 301 | 17 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.78e-30 | 24 | 301 | 17 | 8995226 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 5.52e-30 | 25 | 301 | 17 | 21115691 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 4.10e-29 | 33 | 301 | 18 | 20228807 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 8.64e-29 | 34 | 301 | 18 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 8.64e-29 | 34 | 301 | 18 | 15780755 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 8.64e-29 | 34 | 301 | 18 | 17109758 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 8.64e-29 | 34 | 301 | 18 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 8.64e-29 | 34 | 301 | 18 | 9806828 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 8.64e-29 | 34 | 301 | 18 | 20403174 | |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 8.64e-29 | 34 | 301 | 18 | 19188362 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 8.64e-29 | 34 | 301 | 18 | 11941478 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 8.64e-29 | 34 | 301 | 18 | 20388806 | |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 8.64e-29 | 34 | 301 | 18 | 20368735 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 8.64e-29 | 34 | 301 | 18 | 10936051 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 8.64e-29 | 34 | 301 | 18 | 21448158 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.77e-28 | 35 | 301 | 18 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.77e-28 | 35 | 301 | 18 | 21239494 |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 2.57e-28 | 29 | 301 | 17 | 32527007 | |
| Pubmed | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.50e-28 | 36 | 301 | 18 | 20147298 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 6.77e-28 | 37 | 301 | 18 | 20228808 |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 SP110 USP17L6P USP17L22 USP17L15 USP17L8 | 6.25e-25 | 50 | 301 | 18 | 31806660 |
| Pubmed | MYH10 MYH13 GTPBP6 PPP1R12A NMRAL1 DNAJC21 RPS23 NEB DNAJC7 PGK1 FER1L6 FASN TNRC18 DST KRT71 SCN9A HNRNPA0 CHD6 EEA1 HSPA1L HSPA6 BAHCC1 KRT3 STRN3 SLC25A4 PCDHGA2 KIF21A GPS1 APOB LCP1 SPTBN4 USP8 C2CD3 TRNT1 LATS2 TKT CSPG4 ACIN1 MACF1 IRAK3 MYOM2 EIF2AK4 MAPK6 ATP2B1 DOP1A | 9.83e-14 | 1442 | 301 | 45 | 35575683 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 TMEM120B RAPGEF6 GTPBP6 MYO7A OBSCN IRAK1 EML2 WASHC2A CNTROB RYR1 TBC1D9 MAP3K5 ITPR2 ITPR3 TAOK2 FAM20C BMP8B FASN FAT1 TNRC18 DST SBF1 MFN2 ZNF579 PLXNA1 BAHCC1 ARFGEF2 FAAP100 C6orf132 C2CD3 ARAP3 LATS2 CSNK1G2 CSPG4 LRP4 AKAP13 DOT1L AHNAK2 | 1.18e-13 | 1105 | 301 | 39 | 35748872 |
| Pubmed | GTPBP4 MYH10 PPP1R12A PGK1 MAP3K5 GOLGA8N TAOK2 DST SBF1 GLUL MFN2 RAB2A STRN3 UACA USP28 NTRK2 KIF21A CNTNAP1 RAPGEF4 GOLGA8K PPFIA3 KIF3A SPTBN4 UBE2O OSBPL3 MACF1 CTBP2 RAPGEF2 GOLGA8O PPP6R2 NEURL4 UNC13A TP53BP1 MTSS2 | 4.97e-12 | 963 | 301 | 34 | 28671696 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GTPBP4 MYH10 RAPGEF6 GAPDH PPP1R12A ZMYND8 RBM26 IRAK1 RPS23 ADAR PGK1 STK4 FASN PTPN13 DST ALMS1 MKI67 HELZ STRN3 WASHC2C USP28 EGLN1 LIG3 USP8 UBE2O NAMPT TKT ACIN1 MACF1 JPT1 PPP6R2 TP53BP1 AHNAK2 | 1.03e-11 | 934 | 301 | 33 | 33916271 |
| Pubmed | RAPGEF6 ATR DNAJC21 ITGB3 ITPR1 LPIN1 PHKA2 FREM2 DST SBF1 SUPT5H DSTYK TONSL HELZ TIMELESS SLC25A4 SRRT LIG3 NAMPT ARAP3 OSBPL3 WDCP SLTM AKAP13 EIF2AK4 CRYBG3 PPP6R2 | 2.43e-11 | 650 | 301 | 27 | 38777146 | |
| Pubmed | KIAA0408 USP17L21 USP17L1 USP17L20 IRAK1 FAM25A USP17L19 SPIN4 USP17L18 USP17L17 SORCS2 USP17L13 FAM25G USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 RENBP HHIP USP17L6P IRAK3 FAM25C USP17L22 USP17L15 USP17L8 | 5.49e-11 | 674 | 301 | 27 | 37196079 | |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 8.16e-11 | 10 | 301 | 6 | 24207026 | |
| Pubmed | MYH10 GAPDH MYO7A PPP1R12A RPS23 PGK1 PGM1 ITPR2 STK4 FASN DST SBF1 PTPRZ1 GLUL SORCS2 HNRNPA0 RAB2A STRN3 SLC25A4 CNTNAP1 RAPGEF4 ARFGEF2 IDH2 PPFIA3 KIF3A HAPLN1 SPTBN4 SRRT UBE2O LRIG1 TKT RTRAF GKAP1 KNDC1 MACF1 RAPGEF2 PPP6R2 ATP2B1 UNC13A | 2.78e-10 | 1431 | 301 | 39 | 37142655 | |
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 2.80e-10 | 6 | 301 | 5 | 25966694 | |
| Pubmed | 2.80e-10 | 6 | 301 | 5 | 20519450 | ||
| Pubmed | 2.80e-10 | 6 | 301 | 5 | 23463619 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 2.80e-10 | 6 | 301 | 5 | 16844763 | |
| Pubmed | 3.54e-10 | 12 | 301 | 6 | 24695638 | ||
| Pubmed | 9.73e-10 | 7 | 301 | 5 | 11860456 | ||
| Pubmed | ES cell neural differentiation reveals a substantial number of novel ESTs. | 1.13e-09 | 14 | 301 | 6 | 11793228 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | MYH13 GAPDH NEB DNAJC7 PGM1 RYR1 EHD2 FAM20C SERPINA1 PTPN6 FASN FAT1 PTPN13 GANAB GLG1 GLUL KHK EEA1 RAB2A PCYOX1 COL6A3 UACA NT5E CAPN2 RENBP LCP1 KIF3A SLC3A1 ARSL TKT COASY | 1.59e-09 | 1016 | 301 | 31 | 19056867 |
| Pubmed | MCF2L2 TAOK2 DST ALMS1 BAHCC1 COL17A1 UACA SPTBN4 LRP4 MACF1 UNC13A WDTC1 | 1.65e-09 | 130 | 301 | 12 | 12421765 | |
| Pubmed | USP34 USP17L1 USP17L4 USP17L2 USP28 USP24 USP8 USP17L6P USP17L15 USP17L8 | 2.22e-09 | 81 | 301 | 10 | 12838346 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | USP34 ITPR2 DST SBF1 SUPT5H MKI67 HELZ STRN3 CAPN2 USP24 PDE12 PPP6R2 NEURL4 WDTC1 | 5.79e-09 | 212 | 301 | 14 | 33853758 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | GAPDH MYO7A OBSCN ITGAE CHN1 PGM1 RYR1 PCDH17 ITPR2 FREM2 FAM20C DST EDAR CHD6 FAT4 USP17L12 KIF21A TTI2 RNF213 PPFIA3 LIG3 PDE12 CSNK1G2 AKAP13 IGSF9B | 8.18e-09 | 736 | 301 | 25 | 29676528 |
| Pubmed | CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. | 9.87e-09 | 19 | 301 | 6 | 28067227 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GTPBP4 MYH10 ATR RRP1B GAPDH RBM26 RPS23 DNAJC7 ADAR PGK1 FASN GANAB DIMT1 SUPT5H GLUL MKI67 HNRNPA0 EEA1 RAB2A PLXNA1 PCYOX1 APOB IDH2 RRP1 SRRT LIG3 UBE2O NAMPT PDE12 TKT RTRAF SLTM ACIN1 CTBP2 COASY ATP2B1 | 1.03e-08 | 1425 | 301 | 36 | 30948266 |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | DNAJC7 ADAR STK4 LPIN1 PTPN13 SBF1 HNRNPA0 HELZ DOCK1 CRY2 NAMPT AKAP13 RAPGEF2 WDTC1 | 1.82e-08 | 232 | 301 | 14 | 25515538 |
| Pubmed | MYH10 GAPDH ITGB3 PGM1 ITPR3 EHD2 LPIN1 GANAB DST EEA1 ZNF579 LIG3 TKT ACIN1 MACF1 TP53BP1 AHNAK2 | 2.09e-08 | 360 | 301 | 17 | 33111431 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | MYH10 ATR ITPR3 FASN SBF1 DOCK1 UACA CNTNAP1 ARFGEF2 ARAP3 AKAP13 EIF2AK4 NEURL4 | 2.77e-08 | 202 | 301 | 13 | 33005030 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SF3B4 PHF20 PPP1R12A WASHC2A PGK1 ITPR1 STK4 PHKA2 ERCC8 SERPINA1 FASN GANAB C11orf68 MKI67 HNRNPA0 TIMELESS EEA1 STRN3 WASHC2C SLC25A4 UACA GPS1 TSEN54 LCK FAAP100 CRY2 TKT WDCP NEURL4 TP53BP1 WDTC1 | 3.06e-08 | 1155 | 301 | 31 | 20360068 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | GTPBP4 MYH10 GAPDH RPS23 ADAR PGK1 STK4 FASN DST DIMT1 SBF1 MKI67 HNRNPA0 HSPA1L HSPA6 KIF21A CAPN2 FERMT1 AARSD1 SRRT LIG3 NAMPT PDE12 ARAP3 TKT SLTM ACIN1 MACF1 AKAP13 CTBP2 AKAP10 ATP2B1 TP53BP1 AHNAK2 | 3.12e-08 | 1353 | 301 | 34 | 29467282 |
| Pubmed | GTPBP4 MYH10 SF3B4 GTPBP6 RRP1B GAPDH PPP1R12A RPS23 DNAJC7 ADAR FASN FAT1 GANAB DST GLG1 MKI67 HNRNPA0 MFN2 PISD EEA1 RAB2A HSPA6 PCYOX1 P4HA2 KIF21A CNTNAP1 USP24 APOB RTRAF SLTM MACF1 AKAP13 TP53BP1 | 3.78e-08 | 1297 | 301 | 33 | 33545068 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | USP34 GAPDH PPP1R12A RPS23 DNAJC7 WASHC2A FASN GANAB DIMT1 SUPT5H GLUL HNRNPA0 TIMELESS HSPA1L HSPA6 PRUNE2 STRN3 KIF21A CAPN2 GPS1 USP24 ARFGEF2 AARSD1 SRRT USP8 UBE2O TRNT1 NAMPT PDE12 RTRAF MACF1 CTBP2 AKAP10 COASY AHNAK2 | 5.60e-08 | 1455 | 301 | 35 | 22863883 |
| Pubmed | USP34 GTPBP4 MYH10 RRP1B RPS23 PGK1 ITPR3 FASN GANAB DST SBF1 SUPT5H MKI67 HELZ USP24 LCP1 RRP1 UBE2O SLTM ACIN1 MACF1 TP53BP1 | 7.65e-08 | 653 | 301 | 22 | 22586326 | |
| Pubmed | SF3B4 PPP1R12A RBM26 DNAJC7 SUPT5H MKI67 HNRNPA0 EEA1 UACA LCP1 SRRT PDE12 TKT RTRAF ACIN1 CTBP2 TP53BP1 | 9.23e-08 | 399 | 301 | 17 | 35987950 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYH10 SF3B4 GAPDH PPP1R12A RBM26 RPS23 DNAJC7 ADAR PGK1 PGM1 PHKA2 FASN GANAB DST DIMT1 KRT71 GLUL EEA1 HSPA1L HSPA6 STRN3 IDH2 LCP1 LIG3 UBE2O TKT RTRAF MACF1 JPT1 WDTC1 | 9.43e-08 | 1149 | 301 | 30 | 35446349 |
| Pubmed | PPP1R12A DNAJC7 ITGAL GANAB ALMS1 GLG1 ZNF579 HSPA6 HSPA7 P4HA2 GPS1 CNTNAP1 ARFGEF2 RNF213 UBE2O OSBPL3 MAPK6 ATP2B1 | 1.24e-07 | 457 | 301 | 18 | 22190034 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SF3B4 RAPGEF6 PPP1R12A STK4 PTPN13 DST ALMS1 SBF1 TBC1D1 DSTYK HELZ LCK C6orf132 SRRT USP8 C2CD3 OSBPL3 MACF1 AKAP13 CRYBG3 RAPGEF2 ATP2B1 DOP1A AHNAK2 MTSS2 | 1.67e-07 | 861 | 301 | 25 | 36931259 |
| Pubmed | GTPBP4 MYH10 SF3B4 RRP1B GAPDH PPP1R12A DNAJC21 RPS23 DNAJC7 PGK1 ITPR3 FASN TNRC18 GANAB DIMT1 MKI67 HNRNPA0 MED26 RAB2A UACA NT5E KIF21A KIF3A RRP1 SRRT LIG3 ACIN1 CTBP2 DOT1L PPP6R2 RPAP2 | 1.67e-07 | 1247 | 301 | 31 | 27684187 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TMEM120B RRP1B MYO7A PPP1R12A CDK11A CDC7 STK4 PTPN13 SUPT5H TBC1D1 HELZ PISD MINDY4 EEA1 RAB2A HSPA1L EXOC6 P4HA2 SLC25A4 GPS1 IDH2 FAAP100 KIF3A USP8 OSBPL3 WDCP GKAP1 CTBP2 NEURL4 TP53BP1 INVS WDTC1 | 1.86e-07 | 1321 | 301 | 32 | 27173435 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | USP34 CDK11A DNAJC7 WASHC2A CDC7 ALMS1 SUPT5H TONSL HELZ HSPA1L WASHC2C USP28 WDCP MACF1 CTBP2 CRYBG3 DOT1L PPP6R2 TP53BP1 RPAP2 | 2.61e-07 | 588 | 301 | 20 | 38580884 |
| Pubmed | MYH10 GAPDH RPS23 WASHC2A PGK1 ITPR1 TAOK2 TNRC18 GLG1 GLUL HNRNPA0 HELZ STRN3 WASHC2C NTRK2 CAPN2 CNTNAP1 USP24 IDH2 PPFIA3 UBE2O NAMPT RTRAF KNDC1 MACF1 CRYBG3 PPP6R2 UNC13A TP53BP1 | 2.63e-07 | 1139 | 301 | 29 | 36417873 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | GTPBP4 MYH10 RRP1B GAPDH PPP1R12A DNAJC21 CDK11A RPS23 ADAR ITPR1 ITPR3 FASN GANAB DST DIMT1 MKI67 HNRNPA0 HSPA6 HSPA7 UACA APOB TFAP2A RRP1 TKT OSBPL3 SLTM | 2.85e-07 | 949 | 301 | 26 | 36574265 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | GTPBP4 MYH10 SF3B4 USP17L1 RRP1B ZMYND8 RPS23 ADAR PTPN13 GANAB DST SBF1 SUPT5H HNRNPA0 CHD6 HSPA6 SLC25A4 HMGXB4 IDH2 CGGBP1 AARSD1 RRP1 SRRT LIG3 SLTM ACIN1 MACF1 UNC13A | 3.09e-07 | 1082 | 301 | 28 | 38697112 |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 3.75e-07 | 8 | 301 | 4 | 19033399 | |
| Pubmed | GTPBP4 MYH10 SF3B4 RRP1B PPP1R12A CDK11A RPS23 ADAR ITPR3 DST SUPT5H MKI67 HNRNPA0 UACA NT5E RRP1 SRRT LIG3 ACIN1 MACF1 CTBP2 | 3.88e-07 | 660 | 301 | 21 | 32780723 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | MYH13 MYO7A PPP1R12A ZMYND8 RBM26 OBSCN DNAJC21 CDK11A NEB DNAJC7 RYR3 SERPINA1 SCN9A GPS1 RAPGEF4 LCP1 MYOM2 EIF2AK4 | 4.25e-07 | 497 | 301 | 18 | 36774506 |
| Pubmed | KIAA0408 GAPDH OBSCN NEB PGM1 RYR1 MAP3K5 DST ALMS1 COL6A3 UACA FSD2 ZNF407 KIF3A TKT MACF1 MYOM2 PAX7 | 4.25e-07 | 497 | 301 | 18 | 23414517 | |
| Pubmed | MYH10 SF3B4 RRP1B DNAJC7 CNTROB ITPR1 ITPR2 ITPR3 PTPN6 PTPN13 GANAB SBF1 PTPRZ1 SUPT5H MKI67 HELZ HSPA6 RNF213 PPFIA3 TFAP2A C2CD3 SLTM EIF2AK4 CRYBG3 PPP6R2 ATP2B1 NEURL4 | 5.63e-07 | 1049 | 301 | 27 | 27880917 | |
| Pubmed | 6.42e-07 | 3 | 301 | 3 | 17437169 | ||
| Pubmed | 6.42e-07 | 3 | 301 | 3 | 18547250 | ||
| Pubmed | 6.42e-07 | 3 | 301 | 3 | 36350267 | ||
| Pubmed | 6.42e-07 | 3 | 301 | 3 | 11413485 | ||
| Pubmed | 6.42e-07 | 3 | 301 | 3 | 26009177 | ||
| Pubmed | Receptor-activated single channels in intact human platelets. | 6.42e-07 | 3 | 301 | 3 | 1693919 | |
| Pubmed | 6.42e-07 | 3 | 301 | 3 | 31979185 | ||
| Pubmed | 6.42e-07 | 3 | 301 | 3 | 9808793 | ||
| Pubmed | 6.42e-07 | 3 | 301 | 3 | 18194433 | ||
| Pubmed | Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. | 6.42e-07 | 3 | 301 | 3 | 18241669 | |
| Pubmed | 6.42e-07 | 3 | 301 | 3 | 19068129 | ||
| Pubmed | 6.42e-07 | 3 | 301 | 3 | 17327232 | ||
| Pubmed | 6.42e-07 | 3 | 301 | 3 | 23223241 | ||
| Pubmed | 6.42e-07 | 3 | 301 | 3 | 10874040 | ||
| Pubmed | 6.42e-07 | 3 | 301 | 3 | 20395455 | ||
| Pubmed | 6.42e-07 | 3 | 301 | 3 | 23955339 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 6.42e-07 | 3 | 301 | 3 | 24904548 | |
| Pubmed | Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes. | 6.42e-07 | 3 | 301 | 3 | 9858485 | |
| Pubmed | IP3 receptors regulate vascular smooth muscle contractility and hypertension. | 6.42e-07 | 3 | 301 | 3 | 27777977 | |
| Pubmed | Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. | 6.42e-07 | 3 | 301 | 3 | 17581770 | |
| Pubmed | 6.42e-07 | 3 | 301 | 3 | 16014380 | ||
| Pubmed | 6.42e-07 | 3 | 301 | 3 | 17890015 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. | 6.42e-07 | 3 | 301 | 3 | 23983250 | |
| Pubmed | 6.42e-07 | 3 | 301 | 3 | 20427533 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | MYH10 RRP1B MYO7A SEMA3A GLI2 MKI67 HELZ KIF3A SRRT ACIN1 MACF1 CTBP2 PRKG1 ATP2B1 RPAP2 | 6.56e-07 | 358 | 301 | 15 | 32460013 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | MYH10 GAPDH ISLR PGK1 PGM1 FREM2 SERPINA1 FASN GANAB KRT71 GLG1 NECTIN4 RAB2A HSPA7 GPLD1 KRT3 COL6A3 FAT4 NT5E CRTAC1 APOB IDH2 LCP1 SPTBN4 NAMPT TKT CSPG4 | 8.23e-07 | 1070 | 301 | 27 | 23533145 |
| Interaction | TOP3B interactions | USP34 MYH10 TMEM120B RAPGEF6 GTPBP6 MYO7A OBSCN IRAK1 EML2 WASHC2A CNTROB RYR1 TBC1D9 MAP3K5 ITPR2 ITPR3 TAOK2 FAM20C BMP8B FASN FAT1 TNRC18 DST SBF1 HNRNPA0 MFN2 HELZ ZNF579 PLXNA1 BAHCC1 ARFGEF2 APOB FAAP100 C6orf132 LIG3 C2CD3 NAMPT ARAP3 LATS2 CSNK1G2 CSPG4 GKAP1 LRP4 ACIN1 AKAP13 DOT1L TP53BP1 AHNAK2 | 8.23e-08 | 1470 | 291 | 48 | int:TOP3B |
| Interaction | COX16 interactions | 4.68e-06 | 31 | 291 | 6 | int:COX16 | |
| Interaction | NAA40 interactions | GTPBP4 MYH10 RAPGEF6 GAPDH PPP1R12A ZMYND8 RBM26 IRAK1 RPS23 ADAR PGK1 STK4 FASN PTPN13 DST ALMS1 MKI67 HELZ STRN3 WASHC2C USP28 EGLN1 LIG3 USP8 UBE2O NAMPT TKT ACIN1 MACF1 JPT1 PPP6R2 TP53BP1 AHNAK2 | 5.48e-06 | 978 | 291 | 33 | int:NAA40 |
| Interaction | LRRC31 interactions | MYH10 ATR ITPR3 FASN SBF1 DOCK1 UACA CNTNAP1 ARFGEF2 ARAP3 AKAP13 EIF2AK4 NEURL4 | 9.44e-06 | 205 | 291 | 13 | int:LRRC31 |
| Interaction | KCTD13 interactions | MYH10 GAPDH MYO7A PPP1R12A RPS23 PGK1 PGM1 ITPR2 STK4 FASN DST SBF1 PTPRZ1 GLUL SORCS2 HNRNPA0 RAB2A HSPA1L STRN3 SLC25A4 CAPN2 CNTNAP1 RAPGEF4 ARFGEF2 IDH2 PPFIA3 KIF3A HAPLN1 SPTBN4 SRRT UBE2O LRIG1 TKT RTRAF GKAP1 KNDC1 MACF1 RAPGEF2 PPP6R2 ATP2B1 UNC13A | 1.09e-05 | 1394 | 291 | 41 | int:KCTD13 |
| Interaction | TAFA4 interactions | 1.37e-05 | 55 | 291 | 7 | int:TAFA4 | |
| Interaction | BTNL9 interactions | USP34 CDK11A TBC1D9 TAOK2 SBF1 EXOC6 CRACR2A PPFIA3 RRP1 CSNK1G2 SLTM | 1.72e-05 | 156 | 291 | 11 | int:BTNL9 |
| Interaction | AR interactions | USP34 MYH10 GAPDH ZMYND8 RBM26 RPS23 DNAJC7 ADAR PGK1 ARID5A TNRC18 GLI2 TONSL GLUL FES HNRNPA0 KRT3 SLC25A4 USP28 RNF213 LCK TFAP2A SRRT LIG3 RNASEL LATS2 TKT RTRAF ACIN1 CTBP2 PRKG1 DOT1L | 1.89e-05 | 992 | 291 | 32 | int:AR |
| Interaction | IGLL1 interactions | 1.92e-05 | 12 | 291 | 4 | int:IGLL1 | |
| Interaction | NEK7 interactions | 2.31e-05 | 161 | 291 | 11 | int:NEK7 | |
| Interaction | EEF1AKMT3 interactions | USP34 IRAK1 CDK11A MAP3K5 EHD2 SBF1 TONSL HELZ HSPA1L HSPA7 ODAD2 ARAP3 OSBPL3 AKAP10 EIF2AK4 COASY PPP6R2 | 2.41e-05 | 364 | 291 | 17 | int:EEF1AKMT3 |
| Interaction | HSP90AB1 interactions | GAPDH PPP1R12A IRAK1 CDK11A RPS23 NEB DNAJC7 PGK1 MAP3K5 STK32A FASN TNRC18 HNRNPA0 RAB2A HSPA1L HSPA6 WASHC2C EGLN1 GPS1 LCK GOLGA8Q C6orf132 CRY2 USP8 LATS2 CSNK1G2 ACIN1 UNC13C MAPK6 INVS WDTC1 | 2.52e-05 | 960 | 291 | 31 | int:HSP90AB1 |
| Interaction | NDN interactions | GTPBP4 MYH10 GAPDH RPS23 PGK1 TBC1D9 FASN SUPT5H MKI67 HNRNPA0 HSPA6 FSD2 PPFIA3 SRRT UBE2O ARSL TKT GKAP1 CTBP2 | 3.55e-05 | 453 | 291 | 19 | int:NDN |
| Interaction | IRAG1 interactions | 3.80e-05 | 14 | 291 | 4 | int:IRAG1 | |
| Interaction | TULP3 interactions | PPP1R12A NEB RYR1 MAP3K5 PHKA2 DST SBF1 GLG1 GLI2 TONSL RAB2A GPS1 PPFIA3 KIF3A CTBP2 PPP6R2 | 4.71e-05 | 346 | 291 | 16 | int:TULP3 |
| Interaction | FBXW11 interactions | IRAK1 DNAJC7 ADAR MAP3K5 STK4 LPIN1 PTPN13 SBF1 GLI2 HNRNPA0 HELZ DOCK1 CRY2 NAMPT AKAP13 CTBP2 RAPGEF2 MTSS2 WDTC1 | 6.33e-05 | 473 | 291 | 19 | int:FBXW11 |
| Interaction | CHMP4C interactions | MYH10 GAPDH PPP1R12A RPS23 ADAR PGK1 PGM1 ITPR3 FASN GANAB MKI67 HSPA1L HSPA7 RNF213 RRP1 SPTBN4 USP8 MTX2 TKT RTRAF SLTM ACIN1 MACF1 WDTC1 | 6.51e-05 | 687 | 291 | 24 | int:CHMP4C |
| Interaction | GPR17 interactions | TMEM120B ATR ITPR2 DSTYK TONSL TIMELESS ATP13A3 EXOC6 USP28 TTI2 USP24 ARFGEF2 RNF213 DOP1A | 6.84e-05 | 283 | 291 | 14 | int:GPR17 |
| Interaction | CHN2 interactions | 8.16e-05 | 97 | 291 | 8 | int:CHN2 | |
| Cytoband | 4p16.1 | USP17L21 USP17L23 USP17L20 USP17L19 USP17L18 USP17L17 SORCS2 CLNK USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.69e-21 | 79 | 301 | 17 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L23 USP17L20 USP17L19 USP17L18 USP17L17 SORCS2 CLNK USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.69e-13 | 222 | 301 | 17 | chr4p16 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q13 | 4.62e-06 | 100 | 301 | 7 | chr15q13 | |
| Cytoband | 17p13 | 7.19e-05 | 34 | 301 | 4 | 17p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q25 | 2.15e-04 | 307 | 301 | 9 | chr17q25 | |
| Cytoband | 15q13.2 | 3.40e-04 | 21 | 301 | 3 | 15q13.2 | |
| Cytoband | 17q25.3 | 5.55e-04 | 101 | 301 | 5 | 17q25.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | 8.50e-04 | 298 | 301 | 8 | chr5q31 | |
| Cytoband | 5q31 | 9.99e-04 | 115 | 301 | 5 | 5q31 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 9.07e-07 | 3 | 176 | 3 | 297 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.70e-04 | 29 | 176 | 4 | 396 | |
| GeneFamily | Ubiquitin specific peptidases | 2.11e-04 | 56 | 176 | 5 | 366 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.81e-04 | 3 | 176 | 2 | 287 | |
| GeneFamily | EF-hand domain containing | 3.01e-04 | 219 | 176 | 9 | 863 | |
| GeneFamily | SH2 domain containing | 4.61e-04 | 101 | 176 | 6 | 741 | |
| GeneFamily | Cadherin related | 5.58e-04 | 17 | 176 | 3 | 24 | |
| GeneFamily | Heat shock 70kDa proteins | 5.58e-04 | 17 | 176 | 3 | 583 | |
| GeneFamily | UNC13 homologs | 5.58e-04 | 4 | 176 | 2 | 836 | |
| GeneFamily | Ankyrin repeat domain containing | 6.22e-04 | 242 | 176 | 9 | 403 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 6.64e-04 | 18 | 176 | 3 | 1160 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.02e-03 | 161 | 176 | 7 | 593 | |
| GeneFamily | Ferlin family | 1.38e-03 | 6 | 176 | 2 | 828 | |
| GeneFamily | WASH complex | 1.38e-03 | 6 | 176 | 2 | 1331 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.00e-03 | 181 | 176 | 7 | 694 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.54e-03 | 8 | 176 | 2 | 939 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 4.89e-03 | 11 | 176 | 2 | 455 | |
| GeneFamily | UPF1 like RNA helicases | 4.89e-03 | 11 | 176 | 2 | 1169 | |
| GeneFamily | Tudor domain containing | 5.53e-03 | 37 | 176 | 3 | 780 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 6.88e-03 | 40 | 176 | 3 | 592 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 LPIN1 USP17L17 RAB2A USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 PORCN USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 1.43e-18 | 112 | 295 | 20 | MM1095 |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 9.31e-17 | 86 | 295 | 17 | MM1312 |
| Coexpression | GERY_CEBP_TARGETS | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 3.82e-12 | 160 | 295 | 17 | MM1155 |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | USP17L21 MYH10 USP17L1 GAPDH MYO7A USP17L20 PPP1R12A USP17L19 DNAJC7 PGM1 ITPR2 USP17L18 STK4 USP17L17 PTPRZ1 TBC1D1 SORCS2 MED26 RAB2A USP17L13 COL6A3 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 AARSD1 KIF3A MTX2 OSBPL3 RTRAF GKAP1 USP17L6P CTBP2 COASY USP17L22 ATP2B1 USP17L15 USP17L8 | 8.21e-10 | 1198 | 295 | 40 | MM1062 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L21 USP17L1 USP17L20 USP17L19 ISLR USP17L18 LPIN1 USP17L17 C11orf68 OPLAH PCYOX1 USP17L13 GPLD1 USP17L4 USP17L2 USP17L12 USP17L11 USP17L5 USP17L10 SP110 C6orf132 UBE2O GKAP1 USP17L6P USP17L22 USP17L15 USP17L8 | 6.14e-09 | 647 | 295 | 27 | MM981 |
| Coexpression | GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP | MYH10 TMEM120B PHF20 ZMYND8 FAT1 MAN1A2 C11orf68 COL17A1 ITGA10 CSPG4 MACF1 MYOM2 ATP2B1 | 4.06e-07 | 197 | 295 | 13 | M9569 |
| Coexpression | GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | PTPN6 TBC1D1 SORCS2 KHK CLNK PLXNA1 EXOC6 RAPGEF4 IDH2 TATDN3 RASSF4 INVS | 4.31e-07 | 166 | 295 | 12 | M9100 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L21 USP17L1 USP17L20 USP17L19 ISLR USP17L18 LPIN1 USP17L17 TBC1D1 C11orf68 GLUL KIF17 OPLAH PCYOX1 USP17L13 GPLD1 USP17L4 USP17L2 COL17A1 USP17L12 USP17L11 USP17L5 USP17L10 SP110 C6orf132 LIG3 UBE2O PDE12 RTRAF GKAP1 USP17L6P JPT1 USP17L22 USP17L15 USP17L8 | 4.59e-07 | 1226 | 295 | 35 | MM979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 PHF20 ATR PPP1R12A ZMYND8 ITPR1 FAT1 PTPN13 DST HELZ ATP13A3 DOCK1 STRN3 HMGXB4 USP24 C2CD3 NAMPT MTX2 LRIG1 MACF1 AKAP13 CTBP2 AKAP10 CRYBG3 RAPGEF2 MAPK6 ATP2B1 TP53BP1 | 5.12e-07 | 856 | 295 | 28 | M4500 |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | RRP1B PPP1R12A ZMYND8 MAP3K5 FAT1 MKI67 ATP13A3 USP24 CTBP2 ATP2B1 DOP1A | 8.11e-07 | 145 | 295 | 11 | M1810 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | RRP1B PPP1R12A ZMYND8 MAP3K5 FAT1 DST MKI67 HELZ ATP13A3 HMGXB4 USP24 CTBP2 RAPGEF2 ATP2B1 DOP1A | 1.80e-06 | 300 | 295 | 15 | M8702 |
| Coexpression | RIZKI_TUMOR_INVASIVENESS_3D_DN | GAPDH CHN1 MAP3K5 ITPR2 FASN TONSL HSPA6 COL2A1 SLC25A4 SP110 SRRT TKT PRKG1 | 9.58e-06 | 262 | 295 | 13 | M11472 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L21 USP17L1 USP17L20 USP17L19 ITGAL PGK1 MAP3K5 USP17L18 USP17L17 EEA1 RAB2A USP17L13 USP17L4 USP17L2 USP17L12 NT5E USP17L11 NFKBID USP17L5 USP17L10 ATP10D USP8 DCLRE1C CSNK1G2 USP17L6P MAPK6 USP17L22 USP17L15 USP17L8 | 1.31e-05 | 1072 | 295 | 29 | MM1031 |
| Coexpression | DITTMER_PTHLH_TARGETS_DN | 1.39e-05 | 70 | 295 | 7 | M18667 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | USP34 RAPGEF6 PHF20 ATR GAPDH MYO7A PPP1R12A RBM26 RPS23 ITGAE ITGAL ADAR PGK1 ARID5A ITPR1 ITPR2 STK4 LPIN1 PTPN6 MAN1A2 GLG1 TBC1D1 DSTYK HELZ CAPN2 USP24 RNF213 TSEN54 LCK LCP1 CGGBP1 SP110 CSNK1G2 MACF1 AKAP13 AKAP10 | 1.41e-05 | 1492 | 295 | 36 | M40023 |
| Coexpression | SESTO_RESPONSE_TO_UV_C8 | 1.53e-05 | 71 | 295 | 7 | M2948 | |
| Coexpression | GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP | MYO7A PCYOX1 DOCK1 TTI2 HMGXB4 ATP10D ZNF526 C2CD3 LATS2 CRYBG3 RASSF4 | 1.80e-05 | 200 | 295 | 11 | M8500 |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 3.64e-05 | 81 | 295 | 7 | M39253 | |
| Coexpression | SASSON_RESPONSE_TO_GONADOTROPHINS_UP | 5.36e-05 | 86 | 295 | 7 | M16587 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_MATURE_NK_T_CELL_AGEING | 5.87e-05 | 118 | 295 | 8 | MM3754 | |
| Coexpression | LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX | 5.91e-05 | 152 | 295 | 9 | M39239 | |
| Coexpression | SASSON_RESPONSE_TO_FORSKOLIN_UP | 6.21e-05 | 88 | 295 | 7 | M9869 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ATR PPP1R12A ZMYND8 FAT1 DST HELZ ATP13A3 STRN3 HMGXB4 USP24 C2CD3 MTX2 CTBP2 RAPGEF2 MAPK6 ATP2B1 | 8.67e-05 | 466 | 295 | 16 | M13522 |
| Coexpression | GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN | ATR ITPR1 ERCC8 HNRNPA0 ATP13A3 PRUNE2 NT5E RRP1 OSBPL3 ATP2B1 | 8.84e-05 | 198 | 295 | 10 | M8173 |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 9.22e-05 | 199 | 295 | 10 | M9124 | |
| Coexpression | SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP | 9.80e-05 | 22 | 295 | 4 | M5840 | |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN | 1.46e-04 | 171 | 295 | 9 | M8820 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_UP | 1.52e-04 | 172 | 295 | 9 | M8896 | |
| Coexpression | VILLANUEVA_LIVER_CANCER_KRT19_UP | 1.73e-04 | 175 | 295 | 9 | M336 | |
| Coexpression | ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN | 1.78e-04 | 104 | 295 | 7 | M6189 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | TBC1D1 ATP13A3 DOCK1 RAPGEF4 ARFGEF2 C2CD3 LATS2 WDCP AKAP10 | 2.47e-06 | 91 | 271 | 9 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | MYH10 IRAK1 RPS23 PGM5 STK4 BMP8B MYO3A MOV10L1 SCN9A MKI67 SORCS2 ZNF579 KIF17 COL2A1 COL6A3 TFAP2D FAT3 FERMT1 ARFGEF2 USP17L10 LCK TFAP2A HAPLN1 SPTBN4 SLTM KNDC1 LRP4 MACF1 PAX7 FAM20A | 8.76e-06 | 979 | 271 | 30 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | PPP1R12A PCDH17 RYR3 PGM5 SEMA3A MAN1A2 DST GLI2 SORCS2 ATP13A3 DOCK1 GPLD1 FAT4 COL17A1 FAT3 ARFGEF2 TFAP2A LIG3 HHIP C2CD3 WDCP AKAP13 AKAP10 MYOM2 ZNF646 | 4.20e-05 | 806 | 271 | 25 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_500 | RAPGEF6 PPP1R12A PCDH17 RYR3 PGM5 ITPR1 TBC1D1 ATP13A3 DOCK1 PRUNE2 COL6A3 NT5E NTRK2 AARSD1 HHIP ATP2B1 | 4.96e-05 | 393 | 271 | 16 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | PCDH17 RYR3 PGM5 SEMA3A DST ATP13A3 DOCK1 FAT4 COL17A1 FAT3 ARFGEF2 TFAP2A HHIP C2CD3 WDCP MYOM2 | 7.48e-05 | 407 | 271 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIAA0408 OBSCN NEB RYR3 FREM2 FAT1 SCN9A COL2A1 FAT4 FAT3 APOB ODAD2 UNC13C MYOM2 | 1.88e-11 | 184 | 288 | 14 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIAA0408 OBSCN NEB RYR3 FREM2 FAT1 SCN9A COL2A1 FAT4 FAT3 APOB ODAD2 UNC13C MYOM2 | 1.88e-11 | 184 | 288 | 14 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIAA0408 OBSCN NEB RYR3 FREM2 FAT1 SCN9A COL2A1 FAT4 FAT3 APOB ODAD2 UNC13C MYOM2 | 1.88e-11 | 184 | 288 | 14 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | GAPDH CADM4 PCDH17 DST PTPRZ1 MKI67 COL2A1 KIF21A TFAP2A RLBP1 JPT1 RASSF4 | 6.67e-09 | 197 | 288 | 12 | cd7e34318b4ae72b7b312fda8cc0e041c2ac4ab5 |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | ITGAL ADAR FAT4 USP28 USP24 GOLGA8R RNF213 LCP1 GOLGA8Q MACF1 MYOM2 GOLGA8O | 7.90e-09 | 200 | 288 | 12 | 2281debd86e5d92e8fe0397aec9ef670800f7471 |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | GAPDH CADM4 PCDH17 DST PTPRZ1 COL2A1 KIF21A TFAP2A RLBP1 TKT RASSF4 | 3.88e-08 | 186 | 288 | 11 | 76535681667c8afb884fa72b6edfee9e1e46335b |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | GAPDH CADM4 PCDH17 DST PTPRZ1 SCN9A COL2A1 KIF21A TFAP2A RLBP1 RASSF4 | 5.66e-08 | 193 | 288 | 11 | cdc44bf6f5436eb8a2d4720fe011dcb85ccecf87 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | CHN1 DST EDAR GLI2 COL6A3 FAT4 FAT3 MACF1 IRAK3 UNC13C PRKG1 | 5.97e-08 | 194 | 288 | 11 | b1bb0f846d2865efdd9bc8842b16b9d069785882 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | CHN1 DST EDAR GLI2 COL6A3 FAT4 FAT3 MACF1 IRAK3 UNC13C PRKG1 | 6.29e-08 | 195 | 288 | 11 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | GAPDH CADM4 PCDH17 DST PTPRZ1 CHD6 COL2A1 KIF21A TFAP2A RLBP1 JPT1 | 7.35e-08 | 198 | 288 | 11 | e442692a8a5aad5b84eabbf051d32eae01b1069a |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | GAPDH CADM4 PCDH17 DST PTPRZ1 MKI67 COL2A1 KIF21A TFAP2A RLBP1 JPT1 | 7.35e-08 | 198 | 288 | 11 | a11ac83dbd69d1c068971266d7c7343d114a6294 |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | ITGAL GOLGA8N USP28 GOLGA8R RNF213 TSEN54 LCK GOLGA8Q MACF1 MYOM2 GOLGA8O | 7.73e-08 | 199 | 288 | 11 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | RBM26 PGM1 PCDH17 FAT1 PTPN13 MAN1A2 GANAB ATP13A3 COL2A1 FAT4 GKAP1 | 7.73e-08 | 199 | 288 | 11 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | ITGAL GOLGA8N USP28 GOLGA8R RNF213 TSEN54 LCK GOLGA8Q MACF1 MYOM2 GOLGA8O | 7.73e-08 | 199 | 288 | 11 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CADM4 PCDH17 DST PTPRZ1 SCN9A COL2A1 KIF21A TFAP2A RLBP1 JPT1 RASSF4 | 7.73e-08 | 199 | 288 | 11 | 47466253069d4b1b8f13ce3210f434e60753b38a |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | MYO7A IRAK1 SERPINA1 PTPN6 GLUL MKI67 COL17A1 NFKBID LCP1 NTAN1 AKAP13 | 8.14e-08 | 200 | 288 | 11 | 5f1de1f9305e1784c12d526f6c8bdd7d56229f9b |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PHKA2 ERCC8 PTPN13 NECTIN4 BAHCC1 COL2A1 TSEN54 C6orf132 CTBP2 RASSF4 | 1.53e-07 | 168 | 288 | 10 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | PCDH17 DST PTPRZ1 SCN9A PCDHB1 COL2A1 KIF21A TFAP2A RLBP1 RASSF4 | 1.90e-07 | 172 | 288 | 10 | bc3ed05fdd94d5e1f19285aea867b1453292baec |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | GAPDH CADM4 PCDH17 PTPRZ1 MKI67 COL2A1 KIF21A TFAP2A RLBP1 JPT1 | 3.05e-07 | 181 | 288 | 10 | f2ebeb4941510c4b6e50f2379c574d1778d6ced1 |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CADM4 PCDH17 DST PTPRZ1 SCN9A COL2A1 KIF21A TFAP2A RLBP1 RASSF4 | 3.21e-07 | 182 | 288 | 10 | ecb5624c9074cc6449fad961df54c926c2681d54 |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CADM4 PCDH17 DST PTPRZ1 SCN9A BMP8A KIF21A TFAP2A RLBP1 RASSF4 | 5.50e-07 | 193 | 288 | 10 | d5930f7bd9b299f792212d40a3272a37adf64a82 |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ITPR3 COL2A1 COL6A3 KIF21A ITGA10 HAPLN1 CRY2 CSPG4 FAM25C MTSS2 | 6.64e-07 | 197 | 288 | 10 | 8786125b669d5d0b15e12df0ade6b319f09f7333 |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | GAPDH FAM25A FAT1 PTPN13 PTPRZ1 MKI67 COL17A1 FERMT1 JPT1 AHNAK2 | 6.64e-07 | 197 | 288 | 10 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | GAPDH FAM25A FAT1 PTPN13 PTPRZ1 MKI67 COL17A1 FERMT1 JPT1 AHNAK2 | 6.64e-07 | 197 | 288 | 10 | fb272c9c60ee3d980e528044dc567b4925a23da6 |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CADM4 PCDH17 DST PTPRZ1 SCN9A BMP8A COL2A1 TFAP2A RLBP1 RASSF4 | 6.95e-07 | 198 | 288 | 10 | 5b9a7b9f53a3d9cf8d6e6a7c1c94514b22cf9fa8 |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | GAPDH CADM4 PCDH17 DST PTPRZ1 SCN9A COL2A1 TFAP2A RLBP1 RASSF4 | 6.95e-07 | 198 | 288 | 10 | 36c97eb71b89bac01cabd6a8b728e5a20e52d2a3 |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CADM4 PCDH17 DST PTPRZ1 SCN9A CHD6 COL2A1 KIF21A TFAP2A RLBP1 | 6.95e-07 | 198 | 288 | 10 | c506334d81af672ef9ddc8c4fd2a790bdb58e63e |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | ITGAL GOLGA8N USP28 GOLGA8R RNF213 GOLGA8Q MACF1 CTBP2 MYOM2 GOLGA8O | 7.28e-07 | 199 | 288 | 10 | 5f914962e2572b0c6372465b81b7496fa663d93c |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CADM4 PCDH17 DST PTPRZ1 SCN9A BMP8A KIF21A TFAP2A RLBP1 RASSF4 | 7.28e-07 | 199 | 288 | 10 | 1761669ec514fdb4175042f11b9a31fa5687fc2b |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | GAPDH CADM4 PCDH17 DST PTPRZ1 SCN9A COL2A1 KIF21A TFAP2A RLBP1 | 7.28e-07 | 199 | 288 | 10 | ce699726ac4825c65bf934cb9a76202ad7340596 |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | ITGAL GOLGA8N USP28 GOLGA8R RNF213 GOLGA8Q MACF1 CTBP2 MYOM2 GOLGA8O | 7.28e-07 | 199 | 288 | 10 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | GAPDH CADM4 PCDH17 DST PTPRZ1 SCN9A COL2A1 KIF21A TFAP2A RLBP1 | 7.28e-07 | 199 | 288 | 10 | f1d5808ccb1d5d4e2d34f864e705e2484000e88f |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ITPR1 PTPN6 HSPA7 ARFGEF2 ZNF407 LCP1 IRAK3 AKAP13 FAM20A ATP2B1 | 7.28e-07 | 199 | 288 | 10 | 379bbd9cecf466b902411c54d74bd9885285b1ba |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.62e-07 | 200 | 288 | 10 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | GAPDH CADM4 PCDH17 DST PTPRZ1 SCN9A COL2A1 TFAP2A RLBP1 RASSF4 | 7.62e-07 | 200 | 288 | 10 | de55100e98d3e9b8a74e37aebcd3afa2b0996527 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | KIAA0408 MYH10 PPP1R12A FAT1 DST PRUNE2 COL6A3 HHIP LRP4 PRKG1 | 7.62e-07 | 200 | 288 | 10 | 08bf8c00eee6468215edb3611296bfc8784c4d56 |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | CADM4 PCDH17 DST PTPRZ1 SCN9A COL2A1 KIF21A TFAP2A RLBP1 JPT1 | 7.62e-07 | 200 | 288 | 10 | 553e9612874480f4d2a45671462e266cd0a09321 |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | ITGAL USP28 RNF213 TSEN54 LCK LCP1 GOLGA8Q MACF1 MYOM2 GOLGA8O | 7.62e-07 | 200 | 288 | 10 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-06 | 119 | 288 | 8 | 8eefcf1ace62ad1c90fa5b62ec159c83ec527bf3 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-06 | 171 | 288 | 9 | 8719a18c9e6b6f5d8ec4e937c2bda1e36441c9ec | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-06 | 171 | 288 | 9 | f4cdd7862c8fe99ee765a2f3ed375b584f4976c5 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-06 | 172 | 288 | 9 | e680abead2da75e50774da02384eb2729c839c01 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.07e-06 | 174 | 288 | 9 | 6688424fc4e40c3c4a89669a2bc79369a726f1e6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.07e-06 | 174 | 288 | 9 | 412ccc099028a372b9d953363984c2da54b2187f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.38e-06 | 177 | 288 | 9 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.50e-06 | 178 | 288 | 9 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | RAPGEF6 CHN1 MAP3K5 SUPT5H FES ATP13A3 HSPA1L CRACR2A EIF2AK4 | 3.13e-06 | 183 | 288 | 9 | 310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | ITGAL WASHC2A WASHC2C RNF213 LCP1 GOLGA8Q MACF1 MYOM2 GOLGA8O | 3.13e-06 | 183 | 288 | 9 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-06 | 184 | 288 | 9 | 7712f2e1fae5cdde2d4e355b860dc8536b28e4f6 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-06 | 185 | 288 | 9 | 53a5218c1e6eb12daccde3d6e02f337e2586d74c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-Th1|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.42e-06 | 185 | 288 | 9 | 326c8b6ea0e9140616d7b867db1385b980dc3678 | |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 3.58e-06 | 186 | 288 | 9 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.58e-06 | 186 | 288 | 9 | 7950e03ea080238c168b9d807e217f459acdfb28 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 3.90e-06 | 188 | 288 | 9 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.90e-06 | 188 | 288 | 9 | ed92cddf47defea2f904d36c7ae05ffa323349a9 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.90e-06 | 188 | 288 | 9 | 33afe31b1093d317dc38c324197c6e91bf6c39d3 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | USP34 ITPR1 ATP13A3 USP24 RNF213 ZNF407 MACF1 RAPGEF2 TP53BP1 | 3.90e-06 | 188 | 288 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.08e-06 | 189 | 288 | 9 | b2542b6fcf7bc10d29158d42b03182a939ff135a | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-06 | 189 | 288 | 9 | 6d24414ac6bd4f03f7a5ad3a6eba51d549a7b112 | |
| ToppCell | Non-neuronal-Non-dividing-OPC-OPC|World / Primary Cells by Cluster | 4.08e-06 | 189 | 288 | 9 | ddf5be73912570c32c50f4ac2902da9b590526f8 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.08e-06 | 189 | 288 | 9 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Non-neuronal-Non-dividing-OPC|World / Primary Cells by Cluster | 4.08e-06 | 189 | 288 | 9 | 13848a031ab896b4b24c8319e4745b9b17ff9cfd | |
| ToppCell | Non-neuronal-Non-dividing-OPC-OPC-30|World / Primary Cells by Cluster | 4.08e-06 | 189 | 288 | 9 | 313d165fad541ec6e8dd524b88856e2c93eeb681 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.26e-06 | 190 | 288 | 9 | 5a82709eeb68df4563bb42b97636d110126d2f97 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.26e-06 | 190 | 288 | 9 | da58227565ad6a690828dd8554dd3670222f8582 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.44e-06 | 191 | 288 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|World / Lineage and Cell class | 4.63e-06 | 192 | 288 | 9 | 0703b8ec6960ff975ee5a2737054db67cab016b5 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.83e-06 | 193 | 288 | 9 | 66af80f4b51e1ce97b6fb7c630dc5f95bfa7e7d4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.04e-06 | 194 | 288 | 9 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.04e-06 | 194 | 288 | 9 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.26e-06 | 195 | 288 | 9 | 9fea1ddb68da83ca43dd8006c9e51295b1817f0e | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 5.26e-06 | 195 | 288 | 9 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.48e-06 | 196 | 288 | 9 | 9afd0a7135028a446f06bb68f334e79b8f171b45 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.71e-06 | 197 | 288 | 9 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.71e-06 | 197 | 288 | 9 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.71e-06 | 197 | 288 | 9 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.95e-06 | 198 | 288 | 9 | 50dfe6efca76ea9683a19b6bff59cb5030d346f1 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 5.95e-06 | 198 | 288 | 9 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.95e-06 | 198 | 288 | 9 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.95e-06 | 198 | 288 | 9 | 6e314dc820db9c53fe7fc7c96bed4d7d9a325160 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 5.95e-06 | 198 | 288 | 9 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.19e-06 | 199 | 288 | 9 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.19e-06 | 199 | 288 | 9 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Control-NK|Control / Disease condition and Cell class | 6.19e-06 | 199 | 288 | 9 | f3316fb97c6065286ffd22a0ad9fe7aa5b3b5650 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.19e-06 | 199 | 288 | 9 | 9940f347973bf976ee23fb4b1cf1f349d96c21df | |
| ToppCell | VE-CD4-exh_CD4|VE / Condition, Cell_class and T cell subcluster | 6.19e-06 | 199 | 288 | 9 | 6b00a393ad06ae91bf135a54a53ad4de68956193 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.19e-06 | 199 | 288 | 9 | 5f350d9c7da9ac111bf22623dd4fed7f7983c9fc | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.19e-06 | 199 | 288 | 9 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.19e-06 | 199 | 288 | 9 | 8d13a9ea87f685b5a34b84c4571db6be753cf2d9 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.45e-06 | 200 | 288 | 9 | 16a7c398626b6e82b394eb3ef013bda3a788659d | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 6.45e-06 | 200 | 288 | 9 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.45e-06 | 200 | 288 | 9 | 363a8cebf2ace820661bcb87c7941f6671f8e5f3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 6.45e-06 | 200 | 288 | 9 | 5ba4ed490c64b3bb738e7729669f893fa73aa56f | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.45e-06 | 200 | 288 | 9 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.45e-06 | 200 | 288 | 9 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.45e-06 | 200 | 288 | 9 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.45e-06 | 200 | 288 | 9 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.45e-06 | 200 | 288 | 9 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.45e-06 | 200 | 288 | 9 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.45e-06 | 200 | 288 | 9 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| Drug | Ms B | 2.82e-07 | 37 | 278 | 7 | CID003952261 | |
| Drug | Gvapspat amide | 7.11e-07 | 15 | 278 | 5 | CID000125015 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 7.40e-07 | 7 | 278 | 4 | CID009547999 | |
| Drug | Br2BAPTA | 7.40e-07 | 7 | 278 | 4 | CID003081001 | |
| Drug | Bepridil hydrochloride [74764-40-2]; Down 200; 10uM; MCF7; HT_HG-U133A | EML2 NEB TAOK2 STK4 ERCC8 SERPINA1 DIMT1 EDAR SUPT5H TIMELESS BAHCC1 LIG3 LRIG1 | 8.33e-07 | 194 | 278 | 13 | 5674_DN |
| Drug | Gabapentin [60142-96-3]; Up 200; 23.4uM; MCF7; HT_HG-U133A | PHF20 NEB STK4 DSTYK PRUNE2 ITGA10 CENPO ZNF407 CRTAC1 HAPLN1 PPP6R2 WDTC1 | 4.81e-06 | 193 | 278 | 12 | 7229_UP |
| Drug | mag-fura-2 | 5.31e-06 | 37 | 278 | 6 | CID000123839 | |
| Drug | ptaquiloside | 5.65e-06 | 133 | 278 | 10 | ctd:C043680 | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | ZNF862 ITPR2 STK4 DIMT1 SBF1 GLG1 BAHCC1 GPLD1 FERMT1 AKAP13 RAPGEF2 WDTC1 | 5.93e-06 | 197 | 278 | 12 | 2259_DN |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Up 200; 15.8uM; HL60; HG-U133A | USP34 ATR RRP1B ZMYND8 CHN2 EDAR SBF1 HMGXB4 ITGA10 UBE2O ATP2B1 WDTC1 | 5.93e-06 | 197 | 278 | 12 | 1750_UP |
| Drug | R 478 | 6.71e-06 | 11 | 278 | 4 | CID000084223 | |
| Drug | 8-amino-cADPR | 6.71e-06 | 11 | 278 | 4 | CID003081323 | |
| Drug | monomethyl phthalate | ATR IRAK1 MAP3K5 ITPR1 ITPR2 ITPR3 STK4 PTPN6 MAN1A2 OTOF SUPT5H GLI2 MFN2 EEA1 COL2A1 GPLD1 EXOC6 KRT3 UACA CAPN2 ARFGEF2 APOB LCP1 TFAP2A OSBPL3 PRKG1 DOT1L MAPK6 | 1.88e-05 | 957 | 278 | 28 | ctd:C517284 |
| Drug | 17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | RRP1B RYR1 ITPR1 ITPR3 LPIN1 MFN2 P4HA2 PPFIA3 SP110 PDE12 RAPGEF2 | 2.45e-05 | 191 | 278 | 11 | 993_UP |
| Drug | Cyclosporin A [59865-13-3]; Down 200; 3.4uM; HL60; HT_HG-U133A | ARID5A TBC1D9 PHKA2 SERPINA1 PTPN6 MAN1A2 DSTYK FES ATP13A3 NT5E RASSF4 | 2.69e-05 | 193 | 278 | 11 | 1331_DN |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; HL60; HT_HG-U133A | GTPBP4 ZMYND8 RBM26 GLG1 C11orf68 MFN2 PLXNA1 CAPN2 IDH2 SRRT AKAP13 | 2.83e-05 | 194 | 278 | 11 | 2430_DN |
| Drug | Esculin Hydrate [531-75-9]; Down 200; 11.8uM; PC3; HT_HG-U133A | TMEM120B ZNF862 SBF1 RAB2A CNTNAP1 CENPO FAAP100 PDE12 CSNK1G2 PPP6R2 WDTC1 | 2.96e-05 | 195 | 278 | 11 | 6310_DN |
| Drug | Prazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A | TMEM120B ZMYND8 NEB MAP3K5 TAOK2 SERPINA1 SBF1 IDH2 PPFIA3 CRY2 PPP6R2 | 2.96e-05 | 195 | 278 | 11 | 5416_DN |
| Drug | Ramipril [87333-19-5]; Up 200; 9.6uM; PC3; HT_HG-U133A | STK4 LPIN1 MFN2 RAB2A PLXNA1 FAT4 ITGA10 RRP1 HAPLN1 AKAP13 AKAP10 | 2.96e-05 | 195 | 278 | 11 | 7144_UP |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | GTPBP4 PHF20 ITPR2 TAOK2 DIMT1 DHODH KHK CNTNAP1 CENPO IDH2 SLC3A1 | 3.11e-05 | 196 | 278 | 11 | 5063_DN |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; PC3; HT_HG-U133A | EML2 PCDH17 EHD2 GLI2 PCDHB1 GPLD1 P4HA2 SP110 CRY2 CSPG4 LRP4 | 3.11e-05 | 196 | 278 | 11 | 4443_UP |
| Drug | Succinylsulfathiazole [116-43-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | RRP1B NEB CHN2 MAP3K5 LPIN1 SERPINA1 MAN1A2 DHODH TIMELESS OXLD1 RAPGEF2 | 3.25e-05 | 197 | 278 | 11 | 4265_DN |
| Drug | Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; PC3; HT_HG-U133A | EML2 TAOK2 ALMS1 EDAR GLI2 DHODH MFN2 OXLD1 CENPO TFAP2A WDTC1 | 3.41e-05 | 198 | 278 | 11 | 5099_DN |
| Drug | AC1Q7BER | 3.51e-05 | 6 | 278 | 3 | CID000005702 | |
| Drug | DMSe | 3.63e-05 | 132 | 278 | 9 | CID000020796 | |
| Drug | Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; HL60; HG-U133A | PHKA2 GANAB ALMS1 SUPT5H C11orf68 DHODH USP24 NTAN1 MACF1 AKAP13 PPP6R2 | 3.74e-05 | 200 | 278 | 11 | 1574_DN |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; MCF7; HT_HG-U133A | ZNF862 ITPR2 PHKA2 ALMS1 SBF1 GLG1 FERMT1 IDH2 SP110 CSNK1G2 WDTC1 | 3.74e-05 | 200 | 278 | 11 | 3432_DN |
| Drug | dicyclohexyl phthalate | ATR IRAK1 PGM1 MAP3K5 ITPR1 ITPR2 ITPR3 STK4 PTPN6 MAN1A2 GLG1 MFN2 COL2A1 GPLD1 COL6A3 NUDT16 UACA CAPN2 APOB LCP1 TFAP2A ARAP3 OSBPL3 AKAP13 PRKG1 | 3.77e-05 | 836 | 278 | 25 | ctd:C036042 |
| Drug | riboflavin 5'-phosphate | 5.03e-05 | 171 | 278 | 10 | CID000000710 | |
| Drug | Phosphoryl | PGK1 PGM1 ITPR1 ITPR3 GLUL GPLD1 LIG3 CSNK1G2 PRKG1 MAPK6 ATP2B1 | 7.19e-05 | 215 | 278 | 11 | CID006857426 |
| Drug | XeC compound | 7.62e-05 | 84 | 278 | 7 | CID000005701 | |
| Drug | 3-phosphoglycerate | 8.04e-05 | 114 | 278 | 8 | CID000000724 | |
| Drug | AC1NAT57 | 9.64e-05 | 8 | 278 | 3 | CID004482272 | |
| Drug | Pizotifen malate [5189-11-7]; Up 200; 9.4uM; PC3; HT_HG-U133A | 9.72e-05 | 185 | 278 | 10 | 5072_UP | |
| Drug | AC1L1IZ2 | MYH10 MYH13 PGK1 RYR1 RYR3 PHKA2 MYO3A KHK PORCN LCK KIF3A PRKG1 WDTC1 | 1.01e-04 | 304 | 278 | 13 | CID000004795 |
| Drug | AC1L1CR9 | 1.11e-04 | 21 | 278 | 4 | CID000002023 | |
| Drug | radicicol; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | ZMYND8 ITPR1 TAOK2 LPIN1 PHKA2 SERPINA1 P4HA2 PPFIA3 SP110 CRY2 | 1.16e-04 | 189 | 278 | 10 | 836_UP |
| Drug | NSC759576 | 1.26e-04 | 191 | 278 | 10 | CID000003075 | |
| Drug | Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A | 1.32e-04 | 192 | 278 | 10 | 3252_DN | |
| Drug | Calycanthine [595-05-1]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.38e-04 | 193 | 278 | 10 | 2764_UP | |
| Drug | fura 2 | 1.42e-04 | 65 | 278 | 6 | CID000057054 | |
| Drug | Nifedipine [21829-25-4]; Down 200; 11.6uM; HL60; HT_HG-U133A | ZMYND8 MAP3K5 ITPR2 STK4 LPIN1 ALMS1 SLC25A4 FERMT1 FAAP100 PPP6R2 | 1.44e-04 | 194 | 278 | 10 | 1856_DN |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.44e-04 | 194 | 278 | 10 | 6201_DN | |
| Drug | Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | PHF20 ZNF862 ITPR2 ALMS1 ATP13A3 NT5E CRY2 SRRT MACF1 AKAP10 | 1.44e-04 | 194 | 278 | 10 | 2469_DN |
| Drug | flavoglaucin | 1.49e-04 | 2 | 278 | 2 | CID000119037 | |
| Drug | adenophostin A | 1.49e-04 | 2 | 278 | 2 | ctd:C085029 | |
| Drug | Isocaffeine | 1.49e-04 | 2 | 278 | 2 | CID000001326 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 1.49e-04 | 2 | 278 | 2 | ctd:C005147 | |
| Drug | adenophostin B | 1.49e-04 | 2 | 278 | 2 | CID000656722 | |
| Drug | AC1L9G3A | 1.49e-04 | 2 | 278 | 2 | CID000444302 | |
| Drug | benzene 1,2,4-trisphosphate | 1.49e-04 | 2 | 278 | 2 | CID000192376 | |
| Drug | 5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA | EML2 ITPR1 SERPINA1 DIMT1 PPFIA3 AARSD1 LIG3 PDE12 RNASEL LRIG1 | 1.50e-04 | 195 | 278 | 10 | 834_UP |
| Drug | Benperidol [2062-84-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | PHF20 ITGB3 RYR1 CIITA TIMELESS SPTBN4 PDE12 OSBPL3 MTSS2 WDTC1 | 1.50e-04 | 195 | 278 | 10 | 4781_UP |
| Drug | 5186324; Up 200; 2uM; MCF7; HT_HG-U133A_EA | USP34 RRP1B ZMYND8 NEB MAP3K5 SERPINA1 DIMT1 PLXNA1 PDE12 AKAP13 | 1.50e-04 | 195 | 278 | 10 | 900_UP |
| Drug | Carbarsone [121-59-5]; Up 200; 15.4uM; PC3; HT_HG-U133A | 1.50e-04 | 195 | 278 | 10 | 3991_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A | ITPR2 SEMA3A ERCC8 SBF1 PCYOX1 CNTNAP1 ITGA10 AKAP13 DOP1A INVS | 1.50e-04 | 195 | 278 | 10 | 1732_UP |
| Drug | Selara | 1.53e-04 | 125 | 278 | 8 | CID000150310 | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.56e-04 | 196 | 278 | 10 | 5425_DN | |
| Drug | Cefadroxil [50370-12-2]; Up 200; 11uM; HL60; HT_HG-U133A | ZMYND8 ALMS1 FES BAHCC1 CAPN2 FAAP100 CRY2 UBE2O C2CD3 AKAP13 | 1.56e-04 | 196 | 278 | 10 | 1323_UP |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A | EML2 SERPINA1 MAN1A2 ALMS1 RAB2A BAHCC1 SLC25A4 FERMT1 LIG3 DOP1A | 1.56e-04 | 196 | 278 | 10 | 1164_DN |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A | TMEM120B ZNF862 MAP3K5 SERPINA1 ALMS1 SBF1 DSTYK BAHCC1 CRY2 LIG3 | 1.56e-04 | 196 | 278 | 10 | 5569_DN |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; PC3; HG-U133A | PPP1R12A DNAJC7 ALMS1 RAB2A PLXNA1 STRN3 EGLN1 CNTNAP1 MACF1 RAPGEF2 | 1.56e-04 | 196 | 278 | 10 | 1948_DN |
| Drug | 3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; PC3; HT_HG-U133A | 1.56e-04 | 196 | 278 | 10 | 4664_UP | |
| Drug | Sulpiride [15676-16-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | USP34 EML2 MAN1A2 DSTYK TIMELESS NTRK2 SP110 SRRT LIG3 PPP6R2 | 1.56e-04 | 196 | 278 | 10 | 4389_DN |
| Drug | Prostaglandin E1; Down 200; 10uM; PC3; HT_HG-U133A | CHN2 DIMT1 KHK DOCK1 PPFIA3 PDE12 RNASEL AKAP13 UNC13A DOP1A | 1.56e-04 | 196 | 278 | 10 | 6571_DN |
| Drug | Carisoprodol [78-44-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | TBC1D9 STK4 LPIN1 SERPINA1 IDH2 PPFIA3 FAAP100 HAPLN1 SRRT WDTC1 | 1.56e-04 | 196 | 278 | 10 | 6610_DN |
| Drug | Flunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; PC3; HT_HG-U133A | ARID5A TAOK2 STK4 DHODH RAB2A OXLD1 USP24 FAAP100 ATP10D AKAP13 | 1.56e-04 | 196 | 278 | 10 | 7252_UP |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 1.56e-04 | 196 | 278 | 10 | 1662_DN | |
| Drug | lysosphingomyelin | 1.60e-04 | 160 | 278 | 9 | CID000005263 | |
| Drug | bepridil | 1.62e-04 | 126 | 278 | 8 | CID000002351 | |
| Drug | Raloxifene hydrochloride [82640-04-8]; Down 200; 7.8uM; HL60; HT_HG-U133A | RRP1B EML2 ITPR2 LPIN1 DHODH CAPN2 ARFGEF2 SP110 LIG3 AKAP13 | 1.63e-04 | 197 | 278 | 10 | 2738_DN |
| Drug | 3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; HL60; HT_HG-U133A | 1.63e-04 | 197 | 278 | 10 | 3044_DN | |
| Drug | Minoxidil [38304-91-5]; Up 200; 19.2uM; MCF7; HT_HG-U133A | USP34 ZNF862 EML2 ITGB3 BMP8B USP24 ITGA10 ZNF407 SP110 PDE12 | 1.63e-04 | 197 | 278 | 10 | 1496_UP |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A | ZMYND8 TAOK2 PHKA2 GLG1 MFN2 SRRT LRIG1 PPP6R2 TP53BP1 WDTC1 | 1.63e-04 | 197 | 278 | 10 | 7201_DN |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A | ITPR2 PHKA2 ERCC8 SBF1 HNRNPA0 KHK FAAP100 LRIG1 WDCP RAPGEF2 | 1.63e-04 | 197 | 278 | 10 | 1640_DN |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | USP34 ZNF862 ITPR2 TAOK2 STK4 PPFIA3 TFAP2A CRY2 PPP6R2 RPAP2 | 1.63e-04 | 197 | 278 | 10 | 5576_DN |
| Drug | Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | GTPBP4 ZNF862 MAP3K5 ITPR2 ERCC8 PCDHB1 FERMT1 ARFGEF2 LIG3 AHNAK2 | 1.63e-04 | 197 | 278 | 10 | 6219_UP |
| Drug | Ceftazidime pentahydrate [78439-06-2]; Up 200; 6.2uM; HL60; HG-U133A | USP34 ZMYND8 ARID5A TAOK2 CNTNAP1 CRY2 LIG3 RNASEL INVS WDTC1 | 1.63e-04 | 197 | 278 | 10 | 1721_UP |
| Drug | Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; HL60; HG-U133A | PPP1R12A EML2 MAP3K5 MAN1A2 C11orf68 FES MFN2 PISD RAB2A ATP2B1 | 1.70e-04 | 198 | 278 | 10 | 1609_DN |
| Drug | 5149715; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.70e-04 | 198 | 278 | 10 | 890_DN | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; HL60; HT_HG-U133A | 1.70e-04 | 198 | 278 | 10 | 1300_UP | |
| Drug | Benoxinate hydrochloride [5987-82-6]; Down 200; 11.6uM; HL60; HG-U133A | PPP1R12A MAP3K5 TAOK2 C11orf68 PISD UBE2O AKAP13 RASSF4 TP53BP1 DOP1A | 1.70e-04 | 198 | 278 | 10 | 1976_DN |
| Drug | Omeprazole [73590-58-6]; Down 200; 11.6uM; PC3; HT_HG-U133A | GTPBP4 SERPINA1 GLG1 MKI67 KHK RAB2A COL2A1 TFAP2A ATP10D ARAP3 | 1.70e-04 | 198 | 278 | 10 | 6606_DN |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A_EA | USP34 TBC1D9 MAP3K5 DSTYK MFN2 LCP1 TFAP2A LRIG1 AKAP10 INVS | 1.70e-04 | 198 | 278 | 10 | 1073_DN |
| Drug | Amoxapine [14028-44-5]; Down 200; 12.8uM; HL60; HG-U133A | PPP1R12A TAOK2 PHKA2 SLC25A4 MACF1 AKAP13 RASSF4 ATP2B1 TP53BP1 DOP1A | 1.70e-04 | 198 | 278 | 10 | 2013_DN |
| Drug | Bendroflumethiazide [73-48-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.70e-04 | 198 | 278 | 10 | 3415_UP | |
| Drug | oxaloacetate | 1.70e-04 | 198 | 278 | 10 | CID000000970 | |
| Drug | Niacin [59-67-6]; Down 200; 32.4uM; MCF7; HT_HG-U133A | EML2 SERPINA1 EDAR BAHCC1 STRN3 CENPO RAPGEF2 PPP6R2 AHNAK2 RPAP2 | 1.77e-04 | 199 | 278 | 10 | 3381_DN |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; HL60; HT_HG-U133A | 1.77e-04 | 199 | 278 | 10 | 3063_DN | |
| Drug | Tomatidine [77-59-8]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.77e-04 | 199 | 278 | 10 | 5808_DN | |
| Drug | Ebselen [60940-34-3]; Down 200; 14.6uM; HL60; HT_HG-U133A | GTPBP4 TMEM120B RBM26 EML2 ITPR2 SBF1 DHODH KIF17 TAPBPL PDE12 | 1.77e-04 | 199 | 278 | 10 | 2717_DN |
| Drug | C070379 | 1.77e-04 | 199 | 278 | 10 | CID003034747 | |
| Drug | Nitrofural [59-87-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A | NEB PTPN6 ATP13A3 RAB2A SP110 RNASEL WDCP RWDD2A DOP1A RPAP2 | 1.77e-04 | 199 | 278 | 10 | 5321_DN |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; MCF7; HT_HG-U133A | USP34 ZMYND8 EML2 ITPR2 MFN2 SLC25A4 HMGXB4 CRY2 RNASEL WDTC1 | 1.77e-04 | 199 | 278 | 10 | 2807_DN |
| Drug | Delcorine; Down 200; 8.4uM; HL60; HT_HG-U133A | ZMYND8 NEB MAN1A2 DSTYK DHODH TAPBPL CAPN2 SLC3A1 RNASEL WDTC1 | 1.77e-04 | 199 | 278 | 10 | 2178_DN |
| Drug | strontium | 1.82e-04 | 68 | 278 | 6 | CID000104798 | |
| Drug | Hippeastrine hydrobromide [22352-41-6]; Down 200; 10uM; PC3; HT_HG-U133A | 1.84e-04 | 200 | 278 | 10 | 3682_DN | |
| Drug | 2-Chloropyrazine [14508-49-7]; Up 200; 35uM; MCF7; HT_HG-U133A | TMEM120B PHF20 NEB ITGAL MAP3K5 KHK SP110 LIG3 RNASEL PPP6R2 | 1.84e-04 | 200 | 278 | 10 | 6227_UP |
| Drug | Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.84e-04 | 200 | 278 | 10 | 3935_UP | |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A | USP34 DIMT1 ALMS1 EDAR TIMELESS SRRT AKAP13 RAPGEF2 MTSS2 RPAP2 | 1.84e-04 | 200 | 278 | 10 | 4824_DN |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L21 USP17L1 USP17L20 USP17L19 USP17L18 USP17L17 MOV10L1 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 USP17L8 | 6.58e-27 | 46 | 280 | 19 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L21 USP17L1 USP17L20 USP17L19 ITPR1 USP17L18 USP17L17 CHD6 USP17L13 USP17L4 USP17L2 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P JPT1 USP17L22 USP17L15 USP17L8 | 2.80e-26 | 69 | 280 | 21 | DOID:1682 (implicated_via_orthology) |
| Disease | obesity (implicated_via_orthology) | ITPR1 ITPR2 ITPR3 STK4 LPIN1 BMP8B ALMS1 GLUL BMP8A FAT4 CAPN2 WDTC1 | 1.14e-06 | 215 | 280 | 12 | DOID:9970 (implicated_via_orthology) |
| Disease | WAP four-disulfide core domain protein 3 measurement | 1.66e-05 | 6 | 280 | 3 | EFO_0802220 | |
| Disease | Polydactyly | 1.66e-05 | 117 | 280 | 8 | C0152427 | |
| Disease | Hypoxic Brain Damage | 8.97e-05 | 2 | 280 | 2 | C1140716 | |
| Disease | Anoxia of brain | 8.97e-05 | 2 | 280 | 2 | C0995195 | |
| Disease | Anoxic Encephalopathy | 8.97e-05 | 2 | 280 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 8.97e-05 | 2 | 280 | 2 | C1527348 | |
| Disease | seropositivity measurement, Influenza A seropositivity | 8.97e-05 | 2 | 280 | 2 | EFO_0007034, EFO_0007038 | |
| Disease | serine/threonine-protein kinase MRCK alpha measurement | 8.97e-05 | 2 | 280 | 2 | EFO_0802058 | |
| Disease | lifestyle measurement | PCDH17 ERCC8 HELZ RMC1 BAHCC1 P4HA2 ARFGEF2 ARAP3 CTBP2 ZNF646 | 9.05e-05 | 235 | 280 | 10 | EFO_0010724 |
| Disease | osteoarthritis, knee | 1.40e-04 | 158 | 280 | 8 | EFO_0004616 | |
| Disease | glycoprotein measurement | 1.46e-04 | 119 | 280 | 7 | EFO_0004555 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.75e-04 | 12 | 280 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | Heterotopia, Periventricular, Autosomal Recessive | 2.67e-04 | 3 | 280 | 2 | C1842563 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.67e-04 | 3 | 280 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.67e-04 | 3 | 280 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | neutrophil cytosol factor 2 measurement | 2.67e-04 | 3 | 280 | 2 | EFO_0801837 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 4.44e-04 | 67 | 280 | 5 | EFO_0008595, EFO_0020946 | |
| Disease | ragulator complex protein LAMTOR3 measurement | 5.32e-04 | 4 | 280 | 2 | EFO_0801986 | |
| Disease | protein-tyrosine kinase 2-beta measurement | 5.32e-04 | 4 | 280 | 2 | EFO_0801969 | |
| Disease | ubiquitin carboxyl-terminal hydrolase 8 measurement | 5.32e-04 | 4 | 280 | 2 | EFO_0802179 | |
| Disease | urea transporter 2 measurement | 5.32e-04 | 4 | 280 | 2 | EFO_0802203 | |
| Disease | CUB and Sushi domain-containing protein 2 measurement | 5.32e-04 | 4 | 280 | 2 | EFO_0803314 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 5.51e-04 | 148 | 280 | 7 | C0279702 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 5.54e-04 | 40 | 280 | 4 | EFO_0004746 | |
| Disease | neuroimaging measurement | MYH10 RBM26 EML2 PGM1 TAOK2 SEMA3A SERPINA1 DSTYK BAHCC1 COL2A1 EXOC6 STRN3 FAT3 CAPN2 HAPLN1 HHIP MACF1 CTBP2 AKAP10 PAX7 RAPGEF2 MAPK6 | 6.07e-04 | 1069 | 280 | 22 | EFO_0004346 |
| Disease | Congenital small ears | 6.10e-04 | 41 | 280 | 4 | C0152423 | |
| Disease | sphingosine 1-phosphate measurement | 6.21e-04 | 18 | 280 | 3 | EFO_0800185 | |
| Disease | parahippocampal gyrus volume measurement | 6.21e-04 | 18 | 280 | 3 | EFO_0010318 | |
| Disease | brain measurement, neuroimaging measurement | PGM1 SEMA3A SERPINA1 DSTYK FES BAHCC1 COL2A1 P4HA2 FAT3 HHIP NTAN1 MACF1 CTBP2 AKAP10 | 8.54e-04 | 550 | 280 | 14 | EFO_0004346, EFO_0004464 |
| Disease | nmrA-like family domain-containing protein 1 measurement | 8.80e-04 | 5 | 280 | 2 | EFO_0801844 | |
| Disease | low-density lipoprotein receptor-related protein 1, soluble measurement | 8.80e-04 | 5 | 280 | 2 | EFO_0801772 | |
| Disease | indoleamine 2,3-dioxygenase 1 measurement | 8.80e-04 | 5 | 280 | 2 | EFO_0801695 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.00e-03 | 264 | 280 | 9 | EFO_0008317, EFO_0020944 | |
| Disease | Gastrointestinal Stromal Sarcoma | 1.03e-03 | 47 | 280 | 4 | C3179349 | |
| Disease | Colorectal Carcinoma | GAPDH MCF2L2 OBSCN EML2 ISLR PGM1 LPIN1 FAT1 MKI67 APOB HAPLN1 LIG3 HHIP NAMPT ARAP3 ACIN1 | 1.20e-03 | 702 | 280 | 16 | C0009402 |
| Disease | Gastrointestinal Stromal Tumors | 1.30e-03 | 50 | 280 | 4 | C0238198 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 1.30e-03 | 50 | 280 | 4 | EFO_0022247 | |
| Disease | ETS domain-containing protein Elk-3 measurement | 1.31e-03 | 6 | 280 | 2 | EFO_0801588 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 1.31e-03 | 6 | 280 | 2 | C1854678 | |
| Disease | galectin-7 measurement | 1.31e-03 | 6 | 280 | 2 | EFO_0022034 | |
| Disease | acid ceramidase measurement | 1.31e-03 | 6 | 280 | 2 | EFO_0801339 | |
| Disease | 40s ribosomal protein S3 measurement | 1.31e-03 | 6 | 280 | 2 | EFO_0020117 | |
| Disease | glucagon measurement, glucose tolerance test | 1.31e-03 | 6 | 280 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | plastin-2 measurement | 1.31e-03 | 6 | 280 | 2 | EFO_0801885 | |
| Disease | lon protease homolog, mitochondrial measurement | 1.31e-03 | 6 | 280 | 2 | EFO_0801771 | |
| Disease | primary pulmonary hypertension (is_implicated_in) | 1.31e-03 | 6 | 280 | 2 | DOID:14557 (is_implicated_in) | |
| Disease | riboflavin kinase measurement | 1.31e-03 | 6 | 280 | 2 | EFO_0802016 | |
| Disease | spondyloepiphyseal dysplasia congenita (implicated_via_orthology) | 1.31e-03 | 6 | 280 | 2 | DOID:14789 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.34e-03 | 222 | 280 | 8 | EFO_0008317, EFO_0020943 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 1.37e-03 | 127 | 280 | 6 | EFO_0008595, EFO_0020947 | |
| Disease | Renal Cell Carcinoma | 1.43e-03 | 128 | 280 | 6 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.43e-03 | 128 | 280 | 6 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.43e-03 | 128 | 280 | 6 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.43e-03 | 128 | 280 | 6 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.43e-03 | 128 | 280 | 6 | C1306837 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.46e-03 | 225 | 280 | 8 | EFO_0008317, EFO_0020947 | |
| Disease | triglycerides in medium HDL measurement | 1.73e-03 | 54 | 280 | 4 | EFO_0022321 | |
| Disease | arachidonate 15-lipoxygenase B measurement | 1.83e-03 | 7 | 280 | 2 | EFO_0801391 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 1.83e-03 | 7 | 280 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | Gemistocytic astrocytoma | 1.87e-03 | 26 | 280 | 3 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 1.87e-03 | 26 | 280 | 3 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 1.87e-03 | 26 | 280 | 3 | C0334582 | |
| Disease | triglycerides in very large VLDL measurement | 1.98e-03 | 56 | 280 | 4 | EFO_0022325 | |
| Disease | Glycogen Storage Disease | 2.09e-03 | 27 | 280 | 3 | C0017919 | |
| Disease | Anaplastic astrocytoma | 2.09e-03 | 27 | 280 | 3 | C0334579 | |
| Disease | Hypertrophic Cardiomyopathy | 2.11e-03 | 57 | 280 | 4 | C0007194 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.12e-03 | 239 | 280 | 8 | EFO_0008317, EFO_0020945 | |
| Disease | migraine disorder | PHF20 ZMYND8 NMRAL1 SERPINA1 RNF213 DCLRE1C MACF1 IGSF9B PRKG1 ATP2B1 | 2.32e-03 | 357 | 280 | 10 | MONDO_0005277 |
| Disease | gastric adenocarcinoma (is_marker_for) | 2.32e-03 | 28 | 280 | 3 | DOID:3717 (is_marker_for) | |
| Disease | triglycerides in VLDL measurement | 2.40e-03 | 59 | 280 | 4 | EFO_0022326 | |
| Disease | phospholipids in VLDL measurement | 2.40e-03 | 59 | 280 | 4 | EFO_0022301 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 2.40e-03 | 59 | 280 | 4 | EFO_0022289 | |
| Disease | Idiopathic Myoclonic Epilepsy | 2.42e-03 | 8 | 280 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 2.42e-03 | 8 | 280 | 2 | C0338479 | |
| Disease | Unilateral agenesis of kidney | 2.42e-03 | 8 | 280 | 2 | C0266294 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 2.42e-03 | 8 | 280 | 2 | C0751120 | |
| Disease | Myoclonic Encephalopathy | 2.42e-03 | 8 | 280 | 2 | C0438414 | |
| Disease | Myoclonic Absence Epilepsy | 2.42e-03 | 8 | 280 | 2 | C0393703 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 2.42e-03 | 8 | 280 | 2 | C0393695 | |
| Disease | sialic acid-binding Ig-like lectin 12 measurement | 2.42e-03 | 8 | 280 | 2 | EFO_0802066 | |
| Disease | Syndactyly | 2.42e-03 | 8 | 280 | 2 | C0039075 | |
| Disease | coronary artery disease | RRP1B SERPINA1 DSTYK FES SHOC1 COL2A1 EXOC6 COL6A3 P4HA2 FAT4 ARFGEF2 CENPO RNF213 CRTAC1 APOB LCP1 CSNK1G2 AKAP13 PRKG1 RAPGEF2 ATP2B1 UNC13A | 2.46e-03 | 1194 | 280 | 22 | EFO_0001645 |
| Disease | total lipids in VLDL measurement | 2.55e-03 | 60 | 280 | 4 | EFO_0022314 | |
| Disease | cholesterol to total lipids in IDL percentage | 2.55e-03 | 60 | 280 | 4 | EFO_0022233 | |
| Disease | alpha fetoprotein measurement | 2.68e-03 | 100 | 280 | 5 | EFO_0010583 | |
| Disease | free cholesterol in very large VLDL measurement | 2.71e-03 | 61 | 280 | 4 | EFO_0022274 | |
| Disease | free cholesterol in VLDL measurement | 2.71e-03 | 61 | 280 | 4 | EFO_0022276 | |
| Disease | phospholipids in large VLDL measurement | 2.87e-03 | 62 | 280 | 4 | EFO_0022169 | |
| Disease | total lipids in very large VLDL measurement | 2.87e-03 | 62 | 280 | 4 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 2.87e-03 | 62 | 280 | 4 | EFO_0022299 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 3.05e-03 | 103 | 280 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | Myoclonic Epilepsy | 3.09e-03 | 9 | 280 | 2 | C0014550 | |
| Disease | metabolic syndrome | 3.11e-03 | 200 | 280 | 7 | EFO_0000195 | |
| Disease | fatty acid measurement | SERPINA1 BMP8A EXOC6 CRTAC1 APOB LCP1 NTAN1 GKAP1 MACF1 PPP6R2 TP53BP1 | 3.20e-03 | 436 | 280 | 11 | EFO_0005110 |
| Disease | carcinoma (implicated_via_orthology) | 3.23e-03 | 64 | 280 | 4 | DOID:305 (implicated_via_orthology) | |
| Disease | cholesterol in large VLDL measurement | 3.41e-03 | 65 | 280 | 4 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 3.41e-03 | 65 | 280 | 4 | EFO_0022230 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RDFLHGALERDKKDG | 1161 | Q9UPW8 | |
| ETERNGDDGTHDKGL | 901 | Q9UKV3 | |
| AGADLDKIGLHSDSQ | 531 | Q9UMD9 | |
| RRAGGEFLVKLDHEG | 2231 | Q9P281 | |
| SLEEEGAAHSGKRLR | 446 | Q03989 | |
| EEKDGLLLHAEGAQG | 206 | P78357 | |
| ATAGAARGLGHEELK | 31 | Q8WWN8 | |
| LGKSLHGLYGDNVEE | 311 | P51690 | |
| DGLEGLEKGQFDHAL | 66 | Q4LDR2 | |
| KEGRIRGAALDVHES | 286 | P56545 | |
| EGGEGVLSADHLFVK | 911 | Q6UVK1 | |
| DLEEIGFGSKTRSIH | 2596 | Q68DQ2 | |
| LDSDDHVKIGDFGLA | 856 | Q9P2K8 | |
| NDLIHSVRGDEFLGG | 506 | O43572 | |
| HVLGKALEAAGQDFS | 846 | P33076 | |
| DTIHNFDFLKGLDEG | 151 | Q9H7F0 | |
| GTKADTHDEILEGLN | 91 | P01009 | |
| SEAIGALRGHEDKIR | 201 | Q9NZN4 | |
| NRLGKKGEADRHVFD | 601 | Q9BZE4 | |
| EGAFLHLVSKGGLDR | 196 | Q6V0I7 | |
| NETLDEDLFHKLTGG | 661 | Q9BQL6 | |
| GVLKRESGSDSDLFH | 1431 | Q12802 | |
| REGSLKGHTLAGEEF | 1021 | Q9Y6D5 | |
| EEIKAELFGHGRTTD | 2541 | Q8TCU4 | |
| HKGGDVLALADDGAS | 231 | Q8WXK1 | |
| SLVEGEAVHLARDFG | 291 | P05549 | |
| GGVVILHRKEGDSEF | 311 | Q9BTE6 | |
| EHQGDLGREQGETSK | 706 | Q5JWR5 | |
| DGGFFNRLEDDVHKI | 206 | Q5VSY0 | |
| HEEKVYLSRGDEDLG | 136 | Q9BSW2 | |
| RVTEFGGELHEDGGK | 26 | Q9UFW8 | |
| DDALSLHLRGKGALG | 666 | Q8TEK3 | |
| HLDHNELDALGRGVF | 91 | Q86WK7 | |
| ANHDGDFGITLAELR | 21 | P20020 | |
| RGFLEHSNKERVGLS | 256 | Q9P241 | |
| SLVEGEALHLARDFG | 291 | Q7Z6R9 | |
| GGLRQHDAEVDATLK | 1246 | P02458 | |
| EESFGTGSDHIREKD | 376 | P36871 | |
| KEEGEAFAREHGLIF | 131 | P61019 | |
| AEAEAAAVHGARFKG | 936 | Q5T8P6 | |
| DHFSLDVRRGADGNK | 176 | Q9Y5H1 | |
| LTRDDHGLFGLDVKS | 171 | O14917 | |
| VERKGHLSLEEFSSG | 91 | Q7Z6P3 | |
| EGKSFQLRHREEEGT | 36 | Q9H2L5 | |
| GGDVVRLFHAEQEKF | 236 | Q14571 | |
| QFRDHLEEVLKGGDV | 226 | Q14573 | |
| HSIDGILGDKGNRLD | 186 | P23759 | |
| IGKVHAEDLDLGENA | 471 | Q9Y5F3 | |
| EESFGTGSDHLREKD | 381 | Q15124 | |
| LLDHGEGNFDVDKLS | 966 | Q14517 | |
| RHAQLLDAAKAGGEF | 86 | P51606 | |
| LIFHGVRGSEAREGK | 1016 | Q9BXT6 | |
| LGAADKHGDLREVSL | 566 | H3BQL2 | |
| SVAKRAFSGLEGLEH | 396 | Q96JA1 | |
| TAGRLAAAHFDGKGE | 121 | Q9HBL8 | |
| EGLAHRTEKATEGAI | 11 | B3EWG6 | |
| LAVEAGATRAKDHGL | 121 | Q96DE0 | |
| GATRAKDHGLEVLGL | 126 | Q96DE0 | |
| DDILKGGDVVRLFHA | 231 | Q14643 | |
| GGDVVRLFHAEQEKF | 236 | Q14643 | |
| GHGLQELKAELDAAV | 441 | O43824 | |
| AEGLDAKEEHALALG | 481 | Q9NRM7 | |
| DEEGDTLLHLFAARG | 46 | Q8NI38 | |
| LDGALRQAKGFHGEI | 6481 | Q03001 | |
| IDRDSFKHLIGGLDD | 316 | Q13976 | |
| LEEELGTAHRELGKA | 266 | O75145 | |
| GTAHRELGKAEEANS | 271 | O75145 | |
| RDFQGVLHELSGDKS | 21 | Q5T655 | |
| IHTATKGLIRAFEDG | 206 | Q8NCR3 | |
| KLGELQTTAGRHGDD | 396 | P12035 | |
| HLAESFGLKRDEIGG | 376 | Q9UNE0 | |
| GDEGRLAVHFKTEAQ | 2736 | Q5SZK8 | |
| GKEQSRRDDLEALGH | 226 | P78368 | |
| DEFLGIRHSKESGDF | 291 | Q6ZQW0 | |
| GEDTLGRRFHGKAVE | 351 | O14498 | |
| HGAVFELQKEGREAS | 486 | P38570 | |
| GSHRKFEIASRNGLE | 916 | Q86YR7 | |
| EGLAHRTEKATEGAI | 11 | B3EWG3 | |
| FSSVEKLLHALGGDD | 176 | Q9UHG3 | |
| DGRISFDEFIKIFHG | 66 | P13796 | |
| GRALAHQLGLAEDED | 321 | Q9UIW2 | |
| LTGKTLFAGAHELEQ | 226 | Q16659 | |
| KLGERGHEEGFLNNS | 651 | Q16659 | |
| EKLGELVAGAHALGE | 676 | Q765P7 | |
| EAFGLEGVFRIKQHE | 366 | Q6L8Q7 | |
| SIKESIRRGHDDLGD | 156 | Q13098 | |
| KADHADEVRFVFGGA | 451 | Q6NT32 | |
| ELGAADKHGDLREVT | 566 | H3BV12 | |
| GDDAREAVKHGLNGI | 241 | Q9UJM8 | |
| SSGDFLDLKGEGDIH | 91 | Q9UK76 | |
| DLGQSEFIRTNHKDG | 86 | Q6ZU52 | |
| DKRSRHLGADGVYLD | 386 | Q14693 | |
| HDGDLGFEKGEQLRI | 76 | P06239 | |
| GDTHLGGEDFDNRLV | 226 | P34931 | |
| RLIGEHIDGVSKANF | 71 | Q14952 | |
| ADVAQEHLKERGLFG | 151 | P10070 | |
| GTRNFHKDFLIGEGE | 161 | Q9Y616 | |
| EDLAGFKELFQTRGH | 1586 | P46013 | |
| NLRFHVEEEGKGKDA | 121 | P00558 | |
| KSARDEQGALLLGHE | 226 | Q9UGU5 | |
| RTGHDDDGGFVEKKR | 31 | P61583 | |
| RTGHDDDGGFVEKKR | 31 | P61582 | |
| HESRIGLAEGLESEK | 1621 | P23471 | |
| DNHREALLKGGFDGE | 66 | Q5F1R6 | |
| IQDFLRKGSAGDGFH | 286 | P49916 | |
| SRGTHNFSEELKIGE | 206 | P51617 | |
| FGHIAKAEGDTRFLV | 131 | Q9Y496 | |
| SAELLRAALKDGHSG | 711 | Q0VG06 | |
| RHVLGEGLAKGEDAF | 81 | P42694 | |
| GSRLERDENDKHSGK | 206 | O95402 | |
| QLEAGHSGRLEKTED | 606 | Q6XUX3 | |
| GLSTFKDARHAAEGE | 586 | Q8TAG9 | |
| ELNKDRDVERIHGGG | 31 | Q13216 | |
| GDTHLGGEDFDNRLV | 226 | P48741 | |
| LSVDNAFRHGLIGED | 2521 | Q9UPN3 | |
| AFRHGLIGEDLAEKL | 2526 | Q9UPN3 | |
| GHEAFLLTEGSEEKR | 141 | O95140 | |
| FQDGGERALAALEEH | 111 | Q5BKU9 | |
| HKAAFLGQRGLVEDD | 401 | O95248 | |
| NDERDTFKHLGTGNR | 436 | O15460 | |
| ELGHSGERFLQEDVG | 836 | Q5VST9 | |
| RTGHDDDGGFVEKKR | 31 | P61581 | |
| DHLLAEGDGVLDART | 76 | P60673 | |
| ATLAGAGFTEEKDHL | 266 | Q9H237 | |
| GEKRFESIHDLVTDG | 116 | P52757 | |
| SLEGAARGAAEAKHK | 1121 | Q5T0Z8 | |
| GHGGESNLALKRDDV | 71 | Q15075 | |
| GSIRLGEKDAHSQGE | 251 | Q92896 | |
| GEGKAEFTGRHDAHL | 3011 | P04114 | |
| GNIKHILESLDSEDG | 826 | Q13535 | |
| TRGLEHRGKLDGNQD | 376 | P48735 | |
| GAADKHGDLREVSLT | 566 | D6RF30 | |
| HKGDEERVIGFASVD | 1716 | Q4AC94 | |
| GDLGSVLHLQKADGD | 471 | Q96SD1 | |
| KLDHEVEGGRGDEQY | 1131 | Q14185 | |
| SEALRADKGHIASGQ | 236 | Q8WUS8 | |
| FLEELGEGKATTAHD | 146 | P55265 | |
| GGETEALARLDKHLE | 231 | Q49AN0 | |
| REHGAQAGEGALKDS | 2696 | Q8TD26 | |
| DFGLAQGTHDTKIEL | 196 | O00311 | |
| ETFIIHLDNGRGFGK | 471 | Q8IXL6 | |
| FTDGADGDLADLHRA | 1951 | P12111 | |
| RSNLDKIVDGLGGEH | 4246 | Q8TDW7 | |
| KQHVRDGRKESLDGF | 471 | Q8IX06 | |
| HKDLGLRLYVETEDG | 211 | Q7Z5Y6 | |
| EAFLNGSDGHKRKEE | 371 | Q8NFZ8 | |
| SQLGDDDLKETGFHL | 751 | Q9UQ88 | |
| QIGDEVRALHDTGKF | 221 | Q9GZT9 | |
| VRALHDTGKFTDGQL | 226 | Q9GZT9 | |
| RADKAGHYLELGAEI | 476 | O60476 | |
| GDRIFGLEGSHAENE | 351 | O75578 | |
| LDDSFVRGHLREGKC | 91 | Q99615 | |
| LDGRDGHEVAKDAVS | 311 | Q8IYX4 | |
| TDAKTHIALDGRLAG | 276 | P05106 | |
| AKHLGFQSAEEALRG | 196 | P50053 | |
| QREGEGEEKLSLEAH | 706 | Q76NI1 | |
| GESKGGVLAHLERLE | 11 | Q9BU64 | |
| AHFGLGKDEASSVEV | 491 | Q9NQ79 | |
| RSHDGKLLASADDFG | 581 | O95834 | |
| GDTHLGGEDFDNRLV | 226 | P17066 | |
| RHLGKSEDVLLGETF | 2541 | Q8NDH2 | |
| LERATHADEERLGGK | 5441 | Q8NDH2 | |
| HADEERLGGKTSFVL | 5446 | Q8NDH2 | |
| LGAADKHGDLREVTL | 566 | I6L899 | |
| ELGAADKHGDLREVT | 566 | A6NCC3 | |
| GEKRFESIHDLVTDG | 106 | P15882 | |
| ATHGRFLEIGKFDLS | 1761 | P49327 | |
| HKDLGLRLYVETEDG | 211 | P34820 | |
| KDGELLFVHSAEGSE | 161 | P17655 | |
| DLGEDHSGREGRKNK | 716 | Q9ULU4 | |
| LDKHGDIYGRERIAE | 4726 | P21817 | |
| ERHGFEAASIKEERG | 41 | P35580 | |
| GHNLDRLKAGDTVGV | 626 | Q96JN8 | |
| LKRLEHSGTDGRGDN | 831 | Q8N137 | |
| DDFIRLLHGFNAEGI | 296 | Q9UNQ2 | |
| ERGGQDGKASLEAHR | 671 | O75170 | |
| AIDELDLFGAHGGRK | 211 | P46019 | |
| GTHFIDLRKISNDGD | 511 | Q9HC10 | |
| LHTFNLLRGKTGDDE | 1426 | Q9HC10 | |
| NAHEIEGTVFDRSGK | 731 | Q9H4L5 | |
| AESDGRIHKGDRVLA | 1406 | Q12923 | |
| LVEAEQAKVFSHRGG | 41 | P10915 | |
| KGGARVDLVDQDGHS | 411 | Q9Y283 | |
| IQLRKEGLHEEDGSS | 71 | Q9BVI0 | |
| SAVDERGKDHLRAGK | 221 | Q9P2E2 | |
| GHSLSDGLEEVQKAE | 96 | O75431 | |
| HSGDFLVRESQGKQE | 476 | P07332 | |
| HFGKLDFGETTVLDR | 131 | Q99683 | |
| EGLAHRTEKATEGAI | 11 | B3EWG5 | |
| TEDDHGLDGDRVIGK | 1306 | Q2WGJ9 | |
| KGGLDNARRLTGFHE | 291 | P15104 | |
| VALDKHILGFDTGDA | 181 | Q9Y224 | |
| RELAGVLIFESHAKG | 366 | Q8WZA2 | |
| HKIGNEGLAADLTDD | 281 | Q13033 | |
| LFVKENHELRIAGGA | 51 | Q96Q11 | |
| TFLHEGNDSKVDGLV | 1021 | Q8TEU7 | |
| EQGAEKVLLHAFDGR | 161 | Q17R31 | |
| ALGKNHSRKDGLSDE | 266 | Q14684 | |
| LAKDGAHRGALASSE | 41 | Q9BX59 | |
| SEKEAQGATDRGHLD | 1326 | Q8WUY3 | |
| LDASVQHLEDGDGKR | 186 | Q7Z6J9 | |
| ALGERNHLDLTVEGF | 246 | A0PK00 | |
| AEDKETRDLVRLHGG | 701 | Q5T2S8 | |
| DLLHIGTQARGDLFD | 106 | O14841 | |
| GDDGFLIHLDNARGF | 421 | Q96MK3 | |
| DAGAGIALNDHFVKL | 296 | P04406 | |
| EHADNLRLKVTEGGE | 261 | Q14697 | |
| GEELGLDRSTPKDFH | 6 | A1L4K1 | |
| VGIAAGFDKHGEAVD | 91 | Q02127 | |
| DLVHVEAQDLGGDFR | 306 | Q96PQ0 | |
| LDHGADVNVRGERGK | 226 | Q05823 | |
| KLSLDTDARFGHGSD | 746 | Q9NWH9 | |
| EDSIRRKSFHLGVEG | 506 | Q15858 | |
| FERDLTNKHGIEDIG | 221 | Q5VXU9 | |
| SGIFLDKGEGLIFEH | 636 | Q07837 | |
| KLFSDLREIGHGSFG | 26 | Q9UL54 | |
| GKGDLEEYGQDLLHT | 446 | P43490 | |
| QRAAGGFTHDELLKV | 41 | P56182 | |
| DHVKVIAGRFEGDTG | 476 | O00267 | |
| FFRENAIDGEHSGKA | 246 | Q14563 | |
| HGVKDLEGDGLADVA | 586 | P20701 | |
| LEVHLVGGFSDDRQL | 121 | Q96AB6 | |
| DHFEILRAIGKGSFG | 21 | Q8WU08 | |
| LKDVLGFHEANDGGF | 671 | Q9HB58 | |
| RTGHDDDGGFVEKKR | 31 | P61580 | |
| GNGEDLRLFHSFEEL | 231 | Q9UIY3 | |
| KVQEDTHGRFLLLGD | 211 | Q96PQ1 | |
| IKGGDERGLLSLAFH | 276 | Q96QV1 | |
| KRNRKHSGDDSFDEG | 351 | Q9BXP5 | |
| KIEFDERGNVISSHG | 291 | P21589 | |
| AAEHGQLDALDFLVG | 166 | Q495B1 | |
| LAHEDVAGKDSKFQG | 4616 | Q8IVF2 | |
| LAADVGKGAAQREFH | 141 | P12235 | |
| KVLDEADGDHDGRLS | 151 | Q96Q77 | |
| ERNFAAVLDGAKGHS | 51 | Q7Z7G1 | |
| QRLKGLGAFVIDSDH | 376 | Q13057 | |
| GREDGFTAEHLAAEA | 56 | Q9H3H3 | |
| HNIVLKRELGEGAFG | 536 | Q16620 | |
| DLTFLHEGNDSKVDG | 876 | Q9Y4G8 | |
| DLHKVFIRGGEEFGE | 396 | Q63HN8 | |
| ENDEVLVAGFGRKGH | 96 | P62266 | |
| LSLSNVKGHGRADED | 711 | O15417 | |
| GLADSVKDFQRKGTH | 871 | Q9UNS1 | |
| HAGDRILITGAADSK | 101 | Q8N5D0 | |
| SQALAAGFHRGKQED | 146 | A6NCW7 | |
| EFLHGALGRDKKDGF | 1706 | Q8NB66 | |
| TSKARHDNLDGDVLG | 136 | Q4G0A6 | |
| AKLGHASDRIIALDG | 326 | P29401 | |
| GGHDNISARKFLDAA | 586 | Q96DM3 | |
| GSVAGFLHGENEDEK | 186 | Q6NXR4 | |
| FLHGENEDEKGRLSV | 191 | Q6NXR4 | |
| GSLQFRALSKEDHGE | 471 | Q9UPX0 | |
| KGDVAEGDLIEHFSQ | 106 | Q13151 | |
| DFQLLKEEQSGHSGE | 166 | Q8IXW5 | |
| HFVDLAGSERLKRTG | 271 | Q7Z4S6 | |
| DKLAFDVGLREHATG | 131 | Q15413 | |
| EHAKDDGSKRTGIFI | 206 | Q56A73 | |
| EDEELQGHLGRRKGS | 506 | Q96HA7 | |
| RKGEHLGEFNLGSTI | 366 | Q9UG56 | |
| RKDFESKANHLGDSG | 636 | Q86TI0 | |
| HVVGLDSRSKQGADD | 966 | Q6ZT07 | |
| SQALAAGFHRGKQED | 146 | D6R9N7 | |
| SRFGGVLHLSDLDDD | 716 | P80108 | |
| FGLVRLIHGEDSDSE | 76 | Q9C0C9 | |
| SQALAAGFHRGKQED | 146 | A8MUK1 | |
| LERDETHFQGDKESG | 741 | O15015 | |
| SQALAAGFHRGKQED | 146 | D6R901 | |
| SQALAAGFHRGKQED | 146 | C9JLJ4 | |
| DVEQKRGAEALKGAH | 1831 | Q9UKX3 | |
| KHGLLEGDIAAQSER | 576 | Q9H254 | |
| EARALHQFGADLDGL | 771 | Q9H254 | |
| SQALAAGFHRGKQED | 146 | D6RCP7 | |
| AKSLGHSRGEADLFD | 1096 | Q9Y4E1 | |
| KLLERVFVHGDDLSG | 261 | P12271 | |
| EERGDGNSGFNEHLK | 71 | Q12888 | |
| SQALAAGFHRGKQED | 146 | Q7RTZ2 | |
| RDGSEAGLIKAFHEE | 791 | Q96RU2 | |
| HRDLSGLDAETLLKG | 6 | P29350 | |
| EEFNASFKDGRLHGI | 891 | O60290 | |
| KNGADISLLDALGHD | 221 | Q9BZF9 | |
| SQALAAGFHRGKQED | 146 | C9JPN9 | |
| FAKSLGHSRGEADLF | 1116 | Q641Q2 | |
| LGGFAAIQAKLHSED | 291 | Q9UPU5 | |
| SQALAAGFHRGKQED | 146 | Q0WX57 | |
| QGTHFDSLEKEERNG | 216 | Q8TF50 | |
| SQALAAGFHRGKQED | 146 | P0C7I0 | |
| LLNTEGHAKLADFGV | 156 | Q13043 | |
| KEEFDVSGNGRIEGH | 786 | Q9C0G0 | |
| ARGHGLEDLKGVQED | 1286 | Q9C0G0 | |
| SDVEGGDGLQLRKEH | 16 | Q70CQ2 | |
| SQALAAGFHRGKQED | 146 | Q6QN14 | |
| LTDLRLHSGEVKFGD | 36 | Q9H6R7 | |
| SQALAAGFHRGKQED | 146 | D6RA61 | |
| SQALAAGFHRGKQED | 146 | C9J2P7 | |
| SQALAAGFHRGKQED | 146 | D6RBQ6 | |
| EEVDSKAHLRGLGGL | 546 | Q8NAF0 | |
| VLKRSDDGVFHIGAA | 1351 | Q6BDS2 | |
| RSNLLGHKGEVAEEF | 816 | P40818 | |
| DSKGERHGSAAERLL | 181 | Q15427 | |
| SQALAAGFHRGKQED | 146 | D6RBM5 | |
| SQALAAGFHRGKQED | 146 | Q6R6M4 | |
| SQALAAGFHRGKQED | 146 | D6RJB6 | |
| SQALAAGFHRGKQED | 146 | C9JJH3 | |
| LGEFDQHLKGRTDFI | 296 | Q5TIE3 | |
| SQALAAGFHRGKQED | 146 | C9JVI0 | |
| ELGAADKHGDLREVT | 566 | F8WBI6 | |
| KFQELQLAAGRHGDD | 326 | Q3SY84 | |
| GHIAKIERANLDGSE | 1491 | O75096 | |
| LRKHGLDGEDVSAFL | 481 | P59046 | |
| INLAKGDTGEATRHA | 901 | Q8NEV4 | |
| ETQGFLEKNRDTLHG | 561 | Q13402 | |
| SFAKGDLIILDHDTG | 1626 | Q13402 | |
| FDGKDNHQRSLDLSG | 1306 | P54296 | |
| GDTDEVLKLLHRGAD | 51 | O14974 | |
| QAKGKHIGFRSLEDD | 1826 | P20929 | |
| DAGEGAQELALLHSK | 71 | Q96NY8 |